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ABSTRACT

Novel Quantitative Trait Loci and the Role of Bovine Mammary Epithelial Cells in
Bovine Mastitis Resistance
By
Jacqueline P. Kurz, Doctor of Philosophy
Utah State University, 2017

Major Professor: Dr. Zhongde Wang
Department: Animal, Dairy, and Veterinary Sciences

Bovine mastitis causes substantial economic losses and animal welfare issues in
the dairy industry, making the pursuit of preventative strategies a major area of focus in
the field of dairy science. Identification of genetic markers and the investigation of
underlying mechanisms of the genetic basis of mastitis resistance facilitate the
development of preventative and therapeutic approaches. The main objectives of this
dissertation research were to identify genetic markers of mastitis resistance in Holstein
dairy cattle and to define contributions of bovine mammary epithelial cells, the milksecreting cells of the mammary gland, to mastitis and mastitis resistance.
A genome-wide association study of a population of Holstein dairy cattle was
carried out to identify genetic markers for mastitis resistance. One hundred seventeen
single nucleotide polymorphism genetic markers were detected suggestive of genomewide significance. From these identified genetic markers, 27 regions within the bovine
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genome suggestive of an association with mastitis resistance were defined, of which ten
have not been reported previously.
An in vitro model was used to investigate contributions of bovine mammary
epithelial cells to the mechanisms of mastitis resistance. Differential expression of 42
genes relevant to inflammation by primary bovine mammary epithelial cells from
mastitis-resistant versus mastitis-susceptible cattle was observed following exposure to
bacterial lipopolysaccharide, implicating the bovine mammary epithelial cell as an
important cell type in mastitis resistance.
Comparisons between primary bovine mammary epithelial cells and primary
bovine fibroblasts revealed both similarities and differences in pro-inflammatory gene
expression responses to lipopolysaccharide. This finding emphasizes cell type-specific
contributions to mastitis, which should be considered when selecting an in vitro model.
To facilitate future mastitis studies, a method for the establishment of milk-derived
bovine mammary epithelial cell lines with extended growth potential via transfection
with the viral protein simian virus large T antigen is described.
Examination of the effects of exogenous administration of the enzyme
phospholipase A2 on primary bovine mammary epithelial cells revealed altered
expression of several pro-inflammatory genes in response to lipopolysaccharide. Because
modulation of the inflammatory responses of bovine mammary epithelial cells has the
potential to influence the course of mastitis, this finding highlights phospholipase A2 as a
potential therapeutic candidate.
(217 pages)
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PUBLIC ABSTRACT

Novel Quantitative Trait Loci and the Role of Bovine Mammary Epithelial Cells in
Bovine Mastitis Resistance
Jacqueline P. Kurz

Bovine mastitis, or inflammation of the mammary gland, has substantial
economic and animal welfare implications. A genetic basis for mastitis resistance traits is
recognized and can be used to guide selective breeding programs. The discovery of
regions of the genome associated with mastitis resistance, and knowledge of the
underlying molecular mechanisms responsible, can facilitate development of efficient
mastitis control and therapeutic strategies. The objectives of this dissertation research
were to identify sites of genetic variation associated with mastitis resistance, and to
define the contributions of the milk-secreting epithelial cells to mammary gland immune
responses and mastitis resistance. Twenty seven regions of the bovine genome potentially
involved in mastitis resistance were identified in Holstein dairy cattle. Additionally, this
research demonstrates a role of bovine mammary epithelial cells in mastitis resistance,
and provides guidance for the use of an in vitro model for mastitis studies. Primary
bovine mammary epithelial cells from mastitis-resistant cows have differential expression
of 42 inflammatory genes compared with cells from mastitis-susceptible cows,
highlighting the importance of epithelial cells in mastitis resistance. Bovine mammary
epithelial cells display both similarities and differences in pro-inflammatory gene
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expression compared to fibroblasts, and their expression of inflammatory genes is
influenced by administration of the enzyme phospholipase A2. The growth potential of
milk-derived bovine mammary epithelial cells in vitro can be extended, facilitating their
use in mastitis studies, by transfection with a viral protein. Collectively, this research
contributes to current knowledge on bovine mastitis resistance and in vitro models.
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CHAPTER 1
INTRODUCTION

Mastitis Definition and Pathogens
Mastitis is the costliest disease in the dairy industry [1,2] due to loss of
production, decreased milk quality, discarded milk, labor, veterinary treatments, mastitisrelated culls, and diagnostics [3]. Additionally, the widespread use of preventative
measures against mastitis are an ongoing source of economic losses [4].
Mastitis is defined as inflammation of the mammary gland. Most commonly,
mastitis is a result of invasion of mammary tissue by bacterial pathogens entering through
the teat canal [5], but may also result from invasion by fungal or algal pathogens,
mechanical trauma, chemical injury, or thermal insult [6]. Inflammation results in
temporary or permanent loss of function due to direct microbial and/or inflammatorymediated damage to anatomic components, including the milk-secreting mammary
epithelial cells (MECs). Mastitis is endemic among dairy cattle worldwide, with
prevalence within dairy herds ranging from 5-75%, and among mammary quarters from
2-40% [7].
Bacterial infection is by far the most common cause of mastitis among dairy
cattle. Mastitis-causing bacteria are traditionally categorized as environmental pathogens
or contagious pathogens [5,6,8]. Classification of bacteria into one of these two
categories is based on the predominant source of infection, although overlap may be seen
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with some bacterial strains such as environmental pathogens with host-adapted virulence
factors [9,10].
Important environmental pathogens include Escherichia coli, Streptococcus
uberis, Streptococcus dysgalactiae, Serratia spp., Klebsiella spp., and Enterobacter spp.
[10,11]. In comparison to contagious pathogens, a higher proportion of environmental
pathogens cause clinical, rather than subclinical, mastitis [11]. The source of
environmental pathogens is primarily the cows’ surroundings, where these bacterial
species are normally ubiquitous and capable of long-term survival and growth [6,10].
Manure, bedding, milking equipment, pre- and post-dip preparations, and flies are
common sources [7,10]. Seasonal variation in the incidence of mastitis caused by
environmental pathogens has been observed, with incidence increasing during hot or
damp weather [12]. Entry of environmental pathogens into the teat canal occurs by
propulsion during milking or by passive penetration of the teat canal. Environmental
hygiene and pre-milking teat dipping are important management factors that impact
levels of exposure to environmental pathogens. However, the prevalence of mastitis
caused by environmental pathogens within individual herds is not consistently associated
with management practices traditionally considered to reduce exposure to environmental
pathogens [10]. Despite the widespread implementation of management practices that are
successful in reducing the incidence of contagious mastitis, the control of environmental
mastitis remains a substantial challenge within most dairy herds. As a consequence,
environmental mastitis has become more common than contagious mastitis in the
majority of well-managed herds [10]. Due to the ubiquitous nature of environmental

3
pathogens, antibiotic therapy, with the exception of treatment during the early dry period,
is relatively ineffective in preventing mastitis caused by these pathogens [11].
The universally recognized contagious mastitis pathogens are Staphylococcus
aureus, Streptococcus agalactiae, Mycoplasma spp., and Corynebacterium bovis
[6,7,10]. Contagious pathogens are spread between cows and generally cannot persist
long-term off the host [6,13]. Adherence factors allow colonization of the teat end or teat
canal, and infection of the mammary gland occurs via the teat canal [13]. Hematogenous
spread to the mammary gland or between mammary gland quarters is uncommon but has
been reported for Mycoplasma spp. [14]. Infection most commonly occurs at milking,
where milking equipment and workers’ hands serve as fomites in the spread of the
bacteria between cows.
Mastitis, whether caused by environmental or contagious pathogens, may be
clinical or subclinical. Clinical signs of mastitis include mammary gland edema and
hyperemia, changes to milk appearance or consistency, and/or systemic manifestations
such as pyrexia and obtundation [6,15]. Intramammary infection without clinically
detectable signs is termed subclinical mastitis. Because subclinical mastitis requires
ancillary testing for diagnosis, it may not be readily detected on-farm and so may persist
chronically, resulting in long-term detrimental effects on mammary gland function, milk
quality, and milk somatic cell count (SCC). Staphylococcus aureus, a contagious mastitis
pathogen, is a particularly important cause of chronic, subclinical mastitis in dairy cattle
that is often accompanied by large increases in SCC [16,17]. Somatic cell count is a
measure of the concentration of cells, particularly leukocytes, within milk, and is often
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used as an indicator of intramammary infection status. Somatic cell count is discussed in
further detail below. Strategies used to detect subclinical mastitis include regular
monitoring of SCC, milk electrical conductivity testing to detect changes in ion
concentrations, milk bacterial culture, polymerase chain reaction (PCR)-based pathogen
detection, and assessment of milk pH [18–20]. Several methods exist for SCC
monitoring, ranging from cowside tests (California Mastitis Test) to more precise
methods such as nuclear staining and optical fluorescence (Fossometric SCC; Delaval
cell counter) [20].
Escherichia coli is an environmental pathogen capable of causing mild to severe,
usually clinical mastitis variably accompanied by systemic illness. Escherichia coli has
been used in many bovine mastitis studies because of its importance as a mastitis
pathogen as well as its capacity to induce a strong inflammatory response in the
mammary gland [21]. In this dissertation, lipopolysaccharide (LPS) from E. coli was used
in several studies to stimulate immune responses of bovine MECs. Pathogenicity of E.
coli in intramammary infections generally is not strain-dependent [22,23], except in
instances where host-specific virulence factors develop [9]. Pathogenicity is attributable
predominantly to the presence of LPS, common to all E. coli strains, and is dosedependent [22]. Recognition of the presence of LPS by host cells occurs predominantly
through Toll-like receptor (TLR) 4. Bound TLR4 initiates transcription of various factors
via the NFƙB signaling pathway, ultimately resulting in production of cytokines,
antimicrobial defense proteins, and lipid mediators. Excessive cytokine production
induced by LPS is an important contributor to the severity and clinical signs of E. coli-
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associated mastitis. For example, the degree of production of the cytokine tumor necrosis
factor (TNF) α is an important factor in determining the severity of clinical signs [24].
High levels of TNFα induce both local and systemic effects contributing to the morbidity
and mortality in E. coli mastitis. Locally, TNFα promotes leukocyte-mediated tissue
damage via its effects on leukocyte recruitment, activation, and nitric oxide production.
Tumor necrosis factor α-induced increases in vascular permeability contribute to
mammary gland hyperemia, edema, and altered milk composition due to leakage of
plasma components into the milk. Systemic effects of TNFα include cardiovascular
compromise via decreased cardiac output, systemic vasodilation, and increased vascular
permeability; promotion of a pro-thrombotic state via endothelial cell activation;
induction of pyrexia; and metabolic disturbances [6,25]. Other important
proinflammatory mediators in the pathogenesis of E. coli mastitis include interleukin
(IL)-1, IL-6, IL-8, platelet-activating factor, prostaglandins, and complement components
[25].
Mastitis caused by E. coli occurs most commonly in periparturient or earlylactation cattle, and tends to be most severe in these animals. Intramammary infection by
E. coli is an important cause of acute toxic mastitis in early-lactation cows [26].
Periparturient immunosuppression contributes to the increased incidence and severity of
mastitis during this time. Weak or delayed neutrophil influx following intramammary
infection is of particular relevance in E. coli infection [11,27], particularly when
compounded by bacterial capsule production by some strains. Encapsulation serves a
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protective function in bacteria against neutrophil-dependent defenses and contributes to
prolonged infection by these strains [11].

Innate Immunity of the Bovine Mammary Gland
The pathogenesis of mastitis involves complex interactions between the etiologic
agent and host tissues, influenced by a wide variety of environmental and genetic factors
that contribute to disease susceptibility and outcome of infection [28]. Innate immunity,
comprising relatively non pathogen-specific host responses, plays a particularly important
role in mastitis pathogenesis[29]. Defense mechanisms of innate immunity that are of
particular importance in prevention and elimination of intramammary infection include
the epithelial barrier, secretions in milk, and leukocytes [30].
The teat canal is by far the most common portal of entry for mastitis pathogens
[28]. Adaptations of the teat canal therefore comprise the first barrier to entry and
establishment of pathogens [31,32]. Keratin and lipids continuously produced by
keratinocytes lining the teat canal provide an impermeable barrier to most bacterial
pathogens, and are of particular importance in forming a protective plug during
mammary gland involution and the dry period [28,31,33]. In the lactating cow, the
keratin plug is lost but the teat orifice closes between milkings due to the contraction of
the teat sphincter muscle, which is responsive to acetylcholine and tension from milk fill
[32]. Closure by the teat sphincter following milking takes up to two hours or longer
[28,30], during which time the mammary gland is susceptible to entry by mastitis
pathogens. The common management practice of feeding lactating cows directly
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following milking is in part a measure to reduce mastitis incidence [34], as feeding
activity delays lying behavior, reducing contact between the open teat end and sources of
environmental contamination such as bedding material and manure. Continual shedding
of teat canal keratinocytes as well as the flushing action of milk during milking provide
additional defenses against bacterial colonization of the mammary gland [31].
Mammary epithelial cells lining the teat canal, ductal system, and gland acini
provide a second line of defense. In addition to providing a dynamic physical barrier
against bacterial entry, these cells contribute to inflammatory responses during
intramammary infection [30]. Tight junctions between MECs are a major component of
the physical barrier between the milk space (acinar and cisternal spaces and duct lumens)
and the interstitial space of the mammary gland. The permeability of this barrier varies
with lactational stage and intramammary infection status, and is influenced by factors
such as epithelial growth factor and transforming growth factor β, which in turn are under
hormonal control by prolactin, progesterone, and glucocorticoids [35]. Permeability is
increased, for example, during the dry period in uninfected glands [30]. Impermeability is
important during lactation to prevent microbial entry. However, during active
intramammary infection, permeability is increased as a result of direct damage by
bacterial toxins as well as the influence of pro-inflammatory mediators such as histamine,
TNF α, and interferon γ [25,30]. Although increased permeability may compromise
barrier function, it facilitates entry of effectors of innate immunity into the milk
compartment. Natural (opsonic) antibodies, complement components, transferrin, and
acute-phase proteins are some examples [30].
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Mammary epithelial cells are capable of recognizing antigen from invading
organisms through expression of pattern recognition receptors, including TLRs 2 and 4
[36]. A soluble form of CD14 (sCD14) which binds LPS and facilitates its interaction
with TLR4, is present in milk and is produced by MECs [28,37]. Binding of pathogen
components to TLRs initiates a cellular signal transduction pathway that ultimately leads
to the production of inflammatory mediators. Toll-like receptor 2 binds components of
Gram-positive bacteria, such as lipoteichoic acid and peptidoglycan, while TLR4 binds
mainly LPS. Initially, LPS binding protein binds LPS, subsequently forming a complex
with sCD14. Lipopolysaccharide is then transferred to the LPS receptor complex
composed of TLR4 and lymphocyte antigen 96 (MD2), inducing homodimerization of
TLR4. Transmembrane signaling results in activation of nuclear factors NF-ƙB and
activated protein-1 and initiates production of pro-inflammatory cytokines and
chemokines [6,24,30]. Specific cytokines generated as a result of intramammary infection
vary by pathogen, as demonstrated by in vivo and in vitro studies examining cytokine
expression profiles of MEC challenged with various bacterial species and/or bacterial
components [36,38,39].
Alveolar and ductal MECs additionally produce non-cytokine secreted factors that
contribute to innate immunity. Lactoferrin and citrate from MECs contribute to iron
chelation, which exerts a bacteriostatic effect on bacterial species with high iron
requirements, such as E. coli and S. aureus. Lactoferrin additionally has bactericidal
effects (including synergism with other bactericidal proteins), anti-inflammatory effects
via LPS binding, and modulatory effects on complement activation [30,40]. The enzyme
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xanthine oxidase, derived from milk fat globule membranes produced by MECs,
additionally has bactericidal effects through generation of reactive oxygen species
[30,41].
Neutrophils and macrophages are the major effector leukocytes involved in the
innate immune response against intramammary infection. In the uninfected mammary
gland, macrophages are the predominant cell type in milk, comprising 66-88% of somatic
cells, accompanied by low numbers of neutrophils (<105 cells/ml; 0-11% of milk somatic
cells) [42,43]. Lymphocytes are also present, comprising 10-27% of milk somatic cells,
and are predominantly CD8+ T-lymphocytes expressing the αβ receptor [43]. These
populations shift with intramammary infection.
In the acute stages of inflammation, neutrophils become the predominant cell
type, making up >90% of the total leukocyte population in milk [42]. Neutrophils are
recruited from circulation by inflammatory mediators produced by MECs as well as by
other leukocytes, predominantly macrophages. Inflammatory cytokines such as TNFα
and interleukins (ILs) stimulate the expression of endothelial selectins (E-selectin, Pselectin) and adhesion molecule (intercellular adhesion molecule 1, vascular cellular
adhesion molecule 1) as well as expression of neutrophil adhesion molecule Mac-1,
enabling neutrophil migration from the circulation to sites of inflammation [6,43].
Migration of neutrophils in the extravascular compartment to target sites occurs along
concentration gradients of a number of factors, including complement components C5a
and C3a, LPS, IL-1, IL-2, and IL-8 [30]. Neutrophils act as effector cells of innate
immunity via phagocytosis of bacteria as well as through bactericidal effects of secreted
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molecules. Bactericidal effects are mediated mainly through the respiratory burst, in
which nicotinamide adenine dinucleotide phosphate (NADPH) oxidases produce
superoxide anions which then dismutate into hydrogen peroxide, hydroxyl, and other
reactive oxygen species capable of destroying bacteria [44]. Other anti-microbial
molecules released by neutrophils include defensins, lactoferrin, and bactenecins [30,42].
Although neutrophil numbers are low in the healthy mammary gland, the
concentration and viability of neutrophils in the healthy mammary gland is inversely
related to the risk of intramammary infection and the severity of coliform mastitis.
Additionally, the degree and rapidity of neutrophil recruitment vary between individuals
and are important factors in the outcome of infection [45]. Factors reported to affect the
functionality of neutrophils within the mammary gland include cow parity, stage of
lactation, nutritional/metabolic status, and genetic factors [25,30]. Neutrophils are highly
effective at combating bacterial infection, but their responses secondarily contribute to
mammary gland damage as a result of the release of lysosomal contents, reactive oxygen
species, and tissue disruption associated with trans epithelial migration [25,46,47].
Macrophages comprise 9-32% of milk somatic cells in acutely infected quarters
[43]. These cells are important in pathogen recognition, antigen presentation, and
leukocyte recruitment. Pathogens are destroyed through phagocytosis and exposure to
reactive oxygen species (superoxide, produced from O2 by NADPH oxidase) and
proteases. Phagocytosis is enhanced by opsonization of pathogens by complement
components and by natural or pathogen-specific antibody that is recognized by
macrophage Fc receptors [6,48]. The contribution of macrophages to phagocytosis during
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mastitis is considered fairly minor in comparison with that of neutrophils [43]. More
importantly, macrophages contribute to the innate and adaptive immune response through
secretion of nitric oxide and inflammatory mediators as well as antigen processing and
presentation via major histocompatibility complex (MHC) class II receptors. Activated
macrophages secrete prostaglandins, leukotrienes, and cytokines to influence various
aspects of the inflammatory response, including development and recruitment of other
leukocytes. For example, IL-12 produced by macrophages enhances the development of
CD8+ (cytotoxic) T-lymphocytes while simultaneously driving a TH1 response,
stimulating cell-mediated adaptive immune mechanisms [6,43]. As inflammation
resolves, macrophages participate in phagocytosis and clearing of neutrophils [46,48].
Macrophage function is diminished during the periparturient period, contributing to an
increased susceptibility to intramammary infection during this time [30].
Lymphocyte populations with a role in the response to intramammary infection
include natural killer (NK) cells, CD4+ and CD8+ αβ T-lymphocytes, γδ T-lymphocytes,
and B-lymphocytes. Total lymphocytes comprise 14-24% of milk somatic cells from
infected quarters [43].
Natural killer cells are a subset of cytotoxic lymphocytes capable of exerting their
effects independently of interaction with antigen presented by MHC molecules, and are
an important component of innate immunity [6]. Contributions of NK cells during bovine
mastitis have not yet been fully defined, but cells with NK-like activity have been
demonstrated in the mammary gland [26] and may be an important component of innate
immunity against intramammary infection [28–30]. In general, NK cells identify and
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destroy injured or infected cells via recognition of decreased MHC I expression,
increased expression of activating receptors, and decreased expression of inhibitory
receptors by target cells, and can recognize antibody-bound cells via Fc receptor binding
[6]. Natural killer cells are capable of secreting TNF-α and other factors that promote
pro-inflammatory responses [29].
Besides NK cells, lymphocytes are primarily involved in the adaptive, rather than
innate, immune response. The relative degree of expansion of CD8+ and CD4+ αβ Tlymphocyte populations in response to intramammary infection varies depending on the
causal pathogen and the stage of infection [21,49]. For example, increased lymphocyte
numbers during intramammary infection are due primarily to CD4+ T-lymphocyte
expansion during staphylococcal infection, whereas both CD4+ and CD8+ T-lymphocyte
expansion occurs during streptococcal infection [49]. In the uninfected mammary gland,
B-cell levels remain fairly consistent throughout stages of lactation. In the infected
mammary gland, B-cell differentiation and clonal expansion occurs in response to IL-2
secreted from CD4+ T-lymphocytes, constituting the humoral component of the immune
response [29].
Depression of immunity against mastitis and other diseases during the
periparturient and early lactation periods is a widely-recognized phenomenon in cattle
[50,51]. Several mechanisms are involved, including decreased leukocyte function,
altered leukocyte trafficking, changes in circulating and mammary gland leukocyte
populations, altered cytokine production, and decreased leukocyte survival [51–53].
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Important factors driving these changes include increased glucocorticoid levels
associated with the stress of calving and nutritional and genetic factors [53].

Damage to the Mammary Gland during Mastitis
Mastitis-induced mammary gland damage and disruption of function are
consequences of direct effects of pathogens as well as effects from the host immune
response, namely those associated with leukocyte responses, proteases, and inflammatory
mediators.
The presence of some bacterial components such as LPS can induce apoptosis in
MECs via upregulation of pro-apoptotic factors (Bax, IL-1β-converting enzyme) and
simultaneous downregulation of anti-apoptotic factors such as Bcl-2. Some bacteria, such
as S. aureus, induce apoptosis of MECs and other cells through cellular injury associated
with direct invasion [54]. Direct bacterial effects contribute also to necrosis during
mastitis. Virulence factors of causative bacteria may include toxin production, inducing
cell death through host cellular membrane damage or intracytoplasmic enzymatic
activity. Some pathogens produce effector proteins such as proteinases, while others
induce damage through the production of superantigens [55].
Reactive oxygen species, produced by neutrophils and macrophages during the
respiratory burst, are an important cause of tissue injury and necrosis during mastitis. The
purpose of the respiratory burst is to destroy bacterial pathogens, but local host cells
frequently become casualties during this process. Reactive oxygen species are damaging
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to lipids, proteins, carbohydrates, and nucleic acids, and therefore exert a wide range of
detrimental effects on exposed host cells, including MECs [55].
In addition to production of reactive oxygen species, neutrophils initiate cellular
damage through degranulation. Among other constituents, granules contain neutral and
acidic proteases such as elastase, cathepsins G, B, and D, and matrix metalloproteinase
(MMP). These proteases are capable of damaging mammary gland membrane proteins
and interstitial matrix components, thereby exerting damaging effects on MECs and other
mammary gland components [33].
Inflammatory cytokines such as TNFα produced during mastitis contribute to
increased vascular and MEC barrier permeability. This, in turn, facilitates entry of
potentially damaging plasma proteins into the mammary gland. For example, plasmin and
plasminogen concentrations in the milk increase during mastitis as a result of increased
MEC barrier permeability. The presence of these higher concentrations is further
compounded by release of plasminogen-activating factors from neutrophils and some
bacterial pathogens. Plasmin exerts damaging effects on MECs through direct
degradation of matrix proteins (fibrin, laminin) as well as through activation of MMP
precursors. Other potentially damaging plasma proteins increased in the mammary gland
during mastitis include MMP-9, MMP-2, 120-kDa gelatinase, and stromelysin-1.
Degradation of matrix proteins by these proteases contributes to compromise of MEC
attachment to the extracellular matrix, and thereby to MEC damage [28,55].
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Inflammatory cytokines produced during mastitis may also have direct damaging
effects on host cells. Exposure to TNFα and IL-1 induces apoptosis in bovine endothelial
cells and human MECs. A similar effect on bovine MECs is possible [55].

Changes to Milk during Mastitis
One of the most economically important consequences of mastitis is the decrease
in milk production that accompanies the disease. Damage to MECs, and therefore
reduced production capacity, is a result of direct damage by mastitis pathogens as well as
injury secondary to the inflammatory response [6], as discussed above. Even with
therapeutic intervention, milk production may be affected for several weeks following
intramammary infection before returning to expected levels [56]. Irreversible damage can
occur as a result of severe or prolonged intramammary infection, in which secretory cells
may be sloughed or permanently replaced by fibrous tissue [6]. In these cases, milk
production is affected throughout the current as well as all subsequent lactations.
In addition to lowering the volume of milk produced, mastitis results in
substantial changes in milk composition. Decreases occur in lactose, α-lactalbumin, fat,
and potassium. Increased vascular permeability as a result of inflammation results in
leakage of sodium, chloride, and plasma proteins into the milk, particularly proteins
associated with inflammatory responses. Additional proteins are released by mammary
epithelial cells and leukocytes. Proteins increased in milk from infected quarters include
whey, serum albumin, immunoglobulins, transferrin, lactoferrin, and various enzymes
including xanthine oxidase, acid phosphatase, α1-antitrypsin, and n-Acetyl-β-D-
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glucosaminidase [57,58]. Some of these enzymes, such as plasmin, may alter milk quality
further via cleavage of milk components such as casein both prior to and following
milking [28,58]. The pH of milk from mastitis quarters is frequently elevated due to the
presence of plasma components [58]. During active infection, the causative organisms,
usually bacteria, are present in variable numbers in the milk, and may be accompanied by
bacterial toxins [58,59]. Milk SCC rises as a result of an influx of large numbers of
leukocytes into the milk. In cases of clinical mastitis, milk from affected quarters may
have altered color and/or consistency, often characterized by decreased viscosity with or
without clots due to coagulation of leukocytes and clotting factors [58].

Somatic Cell Count as an Indicator of Intramammary Infection
Measurement of milk SCC is frequently used as a diagnostic indicator of
mammary gland health status. As an indicator of intramammary infection, SCC is used in
the dairy industry in public health regulatory programs as a factor in determining the
suitability of milk for human consumption. In the US dairy industry, for example,
requirements of the Pasteurized Milk Ordinance place a limit on the SCC of milk
(<750,000 cells/ml in Grade A raw milk) [60]. Additionally, SCC limits are used in some
milk quality incentive programs, since mastitis can result in altered milk composition
(discussed previously) and decreased shelf-life [60]. These applications of SCC
measurement demonstrate aspects of the economic importance of minimizing mastitis in
dairy cattle, as high SCC can potentially result in decreased milk value or even exclusion
of milk from the food supply.
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Intramammary infection is by far the largest contributor to an increased SCC, but
a number of other factors can also affect SCC. Variation exists in the degree of SCC
increase between pathogens. Bacteria that elicit marked cellular responses, with resultant
large increases in SCC, are known as major pathogens. Common examples include
coliforms and S. aureus. Infection by major pathogens results in an average SCC of
>600,000 cells/ml [61]. Minor pathogens result in a less pronounced cellular response
and thus a smaller increase in SCC. Minor pathogens include Corynebacterium bovis and
coagulase-negative staphylococci. Infection by minor pathogens can result in SCCs of
near or even less than 200,000 cells/ml [61]. Therefore, detection of cattle infected with
minor pathogens may be poor unless additional testing is not carried out [16].
The stage of infection additionally affects SCC. In experimentally infected cows,
SCC was highest during the acute stages of infection. Variation due to the challenge
organism existed in the time to peak SCC after infection, but occurred within hours to
days [62]. Somatic cell count may be elevated 10 days prior to clinical mastitis in
naturally-infected cows [63] and can persist for variable amounts of time following
clearance of intramammary infection [64,65]. As elevated SCC may persist after an
infection is cleared, a cow in this stage may be falsely classified as actively infected
despite having cleared the causative organism.
The stage of lactation also influences SCC. In uninfected cows, the highest SCC
occurs at drying off, followed by directly after calving, and the lowest occurs from peak
to mid-lactation. This trend is the inverse of milk volume production, suggesting a
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dilution effect [16]. Variation in this trend may be influenced by parity, as somatic cell
linear scores in first-lactation cows may conversely be higher in early lactation [66].
Hourly and daily variations in SCC occur. Hourly variations are influenced by the
milking schedule, with the highest SCC generally detected at milk stripping and within 13 hours after milking. Differences between daily high and low SCC ranges from 4- to 70fold for individual quarters [58]. Therefore, a single daily SCC measurement may not be
representative of overall SCC. Day-to-day variation is particularly of relevance among
infected cows [16].
Because milk somatic cells represent a component of the immune defense against
mastitis pathogens, a low SCC (<200,000 cells per ml during intramammary infection) in
some cattle may indicate a depressed or ineffective immune response to intramammary
infection rather than an absence of intramammary infection. In fact, low SCC has been
reported as a risk factor in the subsequent development of clinical mastitis [67,68].
Somatic cell count is a widely used but imperfect indicator of intramammary
infection status, with the potential to be influenced by the above factors. Measures other
than SCC have been used to determine the infection status of cows. Milk bacterial culture
is useful and can be carried out on-farm [69]. Identification of mastitis pathogens via
PCR or immunoassays provides an alternative to bacterial culture for detection of specific
pathogens, and is becoming more widely available in recent years but may still be costprohibitive [20]. The potential for sample contamination as well as the potential for a lack
of bacterial shedding during intramammary infection must be considered in the
interpretation of pathogen detection methods. Regular observation of milk and the
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mammary gland for changes consistent with mastitis (e.g. altered milk consistency,
visibly inflamed mammary gland tissue) allows for detection of clinical mastitis, but
gives no indication of subclinical mastitis. Tests for biomarkers of mastitis, such as
measurement of milk lactate dehydrogenase levels [70], have been proposed, but the use
of these for commercial purposes has limitations [20]. Reliable determination of infection
status is best achieved through a combination of SCC measurement, pathogen detection,
and examination for clinical mastitis [71].

Factors Influencing Mastitis Resistance
An individual’s phenotype for any given trait, including disease resistance, may be
influenced by genetic and environmental factors. The relative contribution of each of
these factors varies by trait [6,72]. In disease resistance, environmental factors may
include nutritional and metabolic status, age, concurrent disease, hormonal status,
environmental temperatures, and, for infectious diseases, the type and dose of pathogen
exposure. Genetic factors that impact disease severity vary greatly between different
diseases, but by definition include any variation within the genome that influences an
individual’s susceptibility. Many traits are considered quantitative, meaning that the
cumulative influence of and interaction between multiple genes (polygenes) determines
the phenotype. These traits display polygenic inheritance, yielding a continuous gradient
of phenotypes among individuals rather than distinct phenotypic categories [73].
Environmental factors often have substantial influences on expression patterns of the
genotype, thereby contributing to the phenotype (multifactorial inheritance) [28,74].
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Mastitis resistance is a multifactorial, quantitative trait [28,72,75]. In dairy cattle,
recognized external environmental factors influencing mastitis susceptibility are many,
including nutritional management, housing type and management, bedding material,
milking routine, maintenance and performance of milking equipment, season, dry cow
management, and the use of preventative disease programs [12,76–78]. Additional, cowdependent, non-genetic factors include stage of lactation, reproductive status, concurrent
disease, and metabolic status [53,76,79,80]. These factors have variable but often
substantial effects on mastitis traits, and much research has focused on optimizing the
management of environmental factors and milking practices in an effort to decrease
mastitis incidence.
Genetic factors are also known to contribute to mastitis susceptibility. Heritability for
clinical mastitis is reported by most studies to be within the range of 0.003 to 0.17 [81–
88], but has been reported to be as high as 0.42 [89]. Heritability for subclinical mastitis
is reported within the range of 0.04 to 0.14 [87,88], with one study reporting differences
in heritability to subclinical mastitis based on the causative agent [88]. Heritability for
somatic cell score (SCS; a derivative of SCC) is reported within the range of 0.01 to
0.187 [84,90–93]. Although the heritability of mastitis traits appears to be relatively low,
genetic selection for mastitis resistance nevertheless has been demonstrated to reduce the
incidence of mastitis, particularly when genetic markers of mastitis traits are used
[89,94]. Because of the potentially substantial benefits of marker-assisted selection,
discovery of genetic markers of mastitis resistance is an ongoing pursuit within the field
of dairy science.
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An Introduction to Genome-Wide Association Studies
Regions of the genome associated with quantitative traits, such as mastitis
susceptibility, are termed quantitative trait loci (QTLs). Identification of QTLs, and the
specific variants within them associated with phenotype for a given trait, provide the
basis for marker-assisted selection in animal breeding.
Within QTLs, a number of recognized types of variation can influence phenotype.
These include differences in copy numbers of genes, gene segments, or non-coding
sequences (copy number variations, CNVs); micro- and minisatellites; and sequence
polymorphisms [95]. Single nucleotide polymorphisms (SNPs), the most common form
of variation [96], are sites within the genome where allelic variations in a single
nucleotide base are present in greater than 1% of the population. They may occur in
coding or non-coding regions, and can affect gene expression or gene products [95,97].
Single nucleotide polymorphisms have been associated with variations in specific
phenotypic traits in many species, including mastitis traits in cattle.
Single nucleotide polymorphisms significantly associated with a particular trait can
be identified through candidate gene studies or genome-wide association studies
(GWAS). In candidate gene studies, specific genes or genomic regions hypothesized or
known to be relevant to the phenotype of interest are selected and genotyped. These
genotyped regions are then examined for SNPs, and whether specific alleles of these
SNPs vary significantly among phenotypically divergent individuals (e.g. cattle with a
high level of susceptibility versus those with high level of resistance to a disease).
Selection of candidate genes may be based on knowledge of biological function or on
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results of previous genomic studies [97,98]. Genome-wide association studies, on the
other hand, allow genotyping of large numbers of SNPs across the genome. Detection of
SNPs that are significantly associated with the trait of interest is not limited to
previously-identified regions known to be associated with the trait, thus allowing for an
expanded potential to detect novel variants (previously unidentified SNPs) [97]. In the
context of disease, GWAS can potentially highlight previously unknown contributions of
specific genes or regions to disease susceptibility, thereby contributing to elucidation of
disease mechanisms in addition to detection of novel genetic markers. Genome-wide
association studies are appropriate if the common disease/common variant hypothesis is
true, in which a common, complex disease is influenced by genetic variants that are
common within the population. Complex diseases influenced by multiple loci, each with
a small effect, are most well suited to GWAS [98,99].
Using GWAS, the number of SNPs genotyped varies by assay. Low-density (several
thousand SNPs), medium-density, and high-density (hundreds of thousands of SNPs)
arrays are available for GWAS in cattle. Increased marker density increases the power to
detect significant associations [100], and is particularly important when numerous loci
with small effects are studied. Even with high-density arrays, however, only a small
proportion of the total SNPs in the genome are genotyped. Genome-wide association
studies rely on the concept of linkage disequilibrium (LD), defined as the non-random
association of alleles at different loci due to non-random patterns of genetic
recombination [101]. Single nucleotide polymorphisms located together between two
areas in the genome where recombination commonly occurs may be inherited together
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more frequently than would be expected by chance, and thus would be considered in LD
with each other [96]. The degree of LD is commonly expressed as an r2 statistic, defined
as the square of the correlation coefficient between the presence or absence of a specific
allele at one locus and the presence or absence of a specific allele at a second locus [102].
The r2 values range from 0 to 1, where r2 = 1 indicates that specific alleles of the SNPs
are inherited together in all individuals of the study population, whereas r2 = 0 indicates
that the alleles are independently inherited and thus in linkage equilibrium [96]. Linkage
disequilibrium among some groups of SNPs is strong enough that a relatively small
number of associated allele sets, or haplotypes, account for the majority of the variation
at that genomic region within a population. Because of LD, the causal SNP of the
phenotypic variation does not itself need to be genotyped so long as a SNP with which it
is in strong LD is genotyped. Genotyped SNPs in high LD with a causal SNP are called
tag SNPs, and can be used to predict phenotype due to their LD relationship with the
causal SNP [96,98]. In the human genome, for example, LD allows for the majority of
genomic variation to be detected in subjects of European ancestry using 300,000 wellchosen tag SNPs. Single nucleotide polymorphisms can be chosen for GWAS arrays
based on existing knowledge of SNP-phenotype associations, such as that provided by
the human HapMap project, or, more commonly, are an unbiased selection distributed
uniformly across the genome [98].
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Genome-Wide Association Study Methodology
The first step in a successful GWAS is study population selection. Sample size is one
factor that influences the power of detection of significant SNPs, and is particularly
important in detection of rare variants [95,99]. Additionally, robust methods for
phenotypic classification of individuals within the sample population are essential in
order for true associations to be detected [99]. Due to the high expense of GWAS arrays
and data analysis, studies may be carried out as two-stage designs, in which a relatively
small sample size is used initially. Single nucleotide polymorphisms found to be
significantly associated with the trait of interest within the initial sample population can
be selected for further analysis in the second stage of the study, within an expanded
population. Thus, the number of SNPs to be genotyped in the second stage of the study
can be greatly reduced by eliminating SNPs with no evidence of association to the trait.
In some studies, the initial stage is used to select specific areas of the genome to examine
in more detail by increasing marker density at that area for the second stage of the study
[95,98]. For single-stage studies, an approach to reduce sample size while retaining
statistical power has been described (“selective genotyping”). In this approach, only the
phenotypically extreme individuals (e.g. the most highly resistant and most highly
susceptible individuals to a disease) are genotyped; the number of individuals
characterized as phenotypically extreme should not exceed 20-25% of the population
[103]. This approach is based on the assumption that allelic frequencies of causal variants
are most highly divergent between the high and low phenotypic extremes within a
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population. Selective genotyping therefore provides an enrichment effect of causal alleles
within the genotyped population [104].
Genotyping is carried out using a SNP microarray following genomic DNA
isolation and purification. Several SNP array platforms exist, with widely used arrays
available from Affymetrix (Santa Clara, CA) and Illumina (San Diego, CA). Both are
based on hybridization of DNA fragments containing a SNP of interest to a
complimentary oligonucleotide probe on the array, combined with a detection chemistry
to generate nucleotide-specific signals at each SNP site. Affymetrix arrays consist of
short oligonucleotides affixed directly to the array chip surface. Illumina arrays are
microbead-based, with oligonucleotide probes affixed to microbeads on the chip.
Illumina chips are more expensive to manufacture, but have a higher specificity than
Affmetrix arrays due to the use of longer oligonucleotide probes [99].
For analysis using Illumina arrays, genomic DNA is first processed by
fragmentation and whole-genome amplification before hybridization to the array. Each
probe on the array consists of an oligonucleotide sequence complementary to a sample
genomic DNA sequence, with its 3’ end directly adjacent to a SNP site. Hybridization of
genomic DNA to its complementary probe results in overhang of the genomic DNA
fragment directly at the SNP site. Subsequently, single base extension at the 3’ end of the
probe incorporates a labeled nucleotide complementary to the SNP allele. A wash step
then eliminates remaining, unbound labeled nucleotides from the array. The chip is then
scanned, and signals emitted by the labeled nucleotides are recorded. Because each of the
four nucleotides (A, C, T, G) are differentially labeled, and the positions of the
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oligonucleotide probes on the array are known, the signal emitted at each microbead
position is used to determine the allele(s) present at each specific SNP site [105,106].
Pixel values obtained from the array scan are first converted to signal intensity values at
each position. Signal intensities are then subjected to intensive quality control measures,
also called low-level analyses, before the genotype (the allele present at each SNP site)
can be called. Many factors affect signal intensities, including DNA concentration and
differences in probe affinities between individual alleles. Genotype calling algorithms
account for these factors, normalizing signal intensities to facilitate accurate genotype
calling. A number of algorithms have been developed, reviewed elsewhere [98], and
commonly employ a Bayesian approach. Genotypes that cannot be accurately called
following these quality control measures are excluded from the data set. Ultimately, three
signal intensities are possible, indicating that an individual is homozygous for the major
(more common) allele, homozygous for the minor (less common) allele, or heterozygous
[98].
The data are filtered by a number of further quality control steps after genotype
calling. Individual samples for which more than a few SNPs could not be called are
assumed to be of poor quality and are excluded from the data set. In most studies,
samples with a call rate of less than 97% of SNPs are excluded. Individual SNPs for
which genotyping failed in multiple animals are also excluded from the dataset. A
threshold of 2 to 3% is usually set, such that any SNP with a failed call rate above this is
excluded. Additionally, SNPs for which the minor (less common) allele frequency is low
are excluded from the data set, as there is insufficient statistical power to detect a true
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association of these SNPs to the trait using GWAS. Single nucleotide polymorphisms
with minor allele frequencies of less than 1 to 5% are usually excluded [98].
Following quality control measures, GWAS require adjustment for familial
relatedness between animals in order to avoid artificial inflation of significance values.
One method to account for familial relatedness is the genomic best linear unbiased
prediction (gBLUP) method, which generates a marker-based genomic kinship matrix for
integration into the analysis. Covariance between individuals is determined based on
comparison between samples of a large number of genetic markers such as SNPs, and is
used to determine relatedness with more accuracy than pedigree-based methods [107].
The kinship matrix generated by gBLUP is then incorporated into mixed linear model
analysis, with relatedness corrected for as a random effect [108].
Once genotype calling, data filtering, and generation of a kinship matrix have
been completed, data analysis can proceed. Linear regression, the single locus mixed
model (SLMM), and the multi-locus mixed model (MLMM) are three alternative
methods commonly used in GWAS. Of these, the mixed models incorporate both fixed
and random effects, and thus are able to take into account familial relatedness using a
kinship matrix, as discussed above [109,110]. The SLMM detects associations between a
trait and individual markers, examining the relationship of each SNP to the phenotype
independently of other SNPs [110]. The MLMM is used for complex traits influenced by
multiple moderate- to large-effect loci, and examines interaction effects between SNPs
throughout the genome. It employs a stepwise mixed model regression and a forward
inclusion and backward elimination of multiple loci as cofactors, thereby reducing

28
confounding effects of background loci across the genome. Compared with the single
locus MLM, the MLMM generally yields lower false detection rates (FDR) and higher
power [108,110].
In mixed model analysis, a genetic model must be specified. An additive,
dominant, recessive, or multiplicative inheritance pattern is selected based on knowledge
from previous studies, if available [99,108]. Frequently, the inheritance pattern of the
SNPs of interest is unknown. In these cases, the additive inheritance model is selected, as
this has the power to detect both additive and dominant effects. Additive inheritance
assumes a linear, uniform increase in risk for expression of the phenotype in question
(e.g. disease susceptibility) for each copy of the risk-associated allele. In other words, if
two alleles, a and A, exist for a particular SNP, and the A allele is associated with
increased disease susceptibility, an animal with the genotype AA will be twice as diseasesusceptible as an animal with the Aa genotype. If an animal with the Aa genotype is three
times more susceptible to developing the disease than an animal with the aa genotype, an
animal with the AA genotype will be twice as susceptible than the Aa animal, or six times
more susceptible than the aa animal. The dominant model, on the other hand, assumes
equal risk for Aa and AA animals, while the recessive model assumes that an animal must
have two copies of the causative allele (AA) in order to have increased susceptibility. The
multiplicative model assumes that an animal with the genotype AA is x2 more susceptible
than an animal with the Aa genotype. [99].
Depending on the study population, additional covariates (other known factors
that may influence the trait) must be considered and incorporated into the model if
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appropriate. These may include population stratification (e.g. different ethnic groups),
sex, age, and study site [99,108].
Due to the large number of individual statistical tests carried out in mixed model
analysis, p-values generated by the analysis must be corrected for multiple testing. The
Bonferroni and FDR methods are two commonly used methods. The Bonferroni
correction adjusts the false positive rate for the number of statistical tests; the alpha value
(significance value) is divided by the number of statistical tests run. This method assumes
that each association test for every SNP is independent of all other tests, and therefore
does not account for LD. The FDR method allows adjustment of the false positive rate
through providing an estimate of the proportion of significant results that are false
positives [99]. This method has increased power over the Bonferroni method, with an
increasing advantage as the number of tests increase, but may overestimate false positives
[111].
The corrected p-values indicate the level of association between each SNP and the
trait of interest. A universal threshold for genome-wide significance has not been
established, although 5.5 x 10-8 has been suggested by the International HapMap
Consortium [112] and has been used in many GWAS [98,113]. However, less stringent
thresholds have been proposed to account for factors such as allele frequency [113] and
LD [98]. Recently, guidelines for determining appropriate significance thresholds
adapted for individual GWAS have been suggested [113].
Although GWAS provide a powerful tool for genetic marker discovery, the risk of
falsely identifying associations is a notable limitation [114]. Follow-on studies are
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therefore required to validate GWAS findings, and should include replication of results in
a separate but comparable and ideally expanded population [114]. Consideration of the
functional relevance (known or demonstrable influences on the phenotype of interest) of
candidate genes identified by GWAS can also assist in distinguishing false positives from
true associations and serve as a guide for the direction of follow-on studies [115,116].

The Application of Marker-Assisted Selection for Mastitis Traits
In livestock species, selection for health or production traits may be based on
phenotypic measures or the use of genetic marker-assisted methods for single-gene or
quantitative traits [117]. The potential for marker-assisted methods to improve the
efficiency and precision of selection over conventional methods has been demonstrated in
a number of production species. In dairy cattle, for example, marker-assisted selection for
decreased SCS in first-lactation heifers resulted in a higher level of discrimination
between high and low SCS heifers than did a conventional strategy relying on parental
relative estimated breeding values for SCS [94]. Similar conventional and markerassisted selection strategies were used in a separate study to identify mastitis-resistant and
mastitis-susceptible cattle [118]. In that study, primary MECs from cattle within the
marker-assisted groups displayed marked differences in inflammatory gene expression
between resistant and susceptible cattle following challenge by E. coli and S. aureus. In
contrast, differences in inflammatory gene expression by MECs between resistant and
susceptible cattle within the conventionally selected group were limited to a single gene,
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at a single timepoint, after challenge by E. coli only. These and other studies illustrate the
potential of marker-assisted selection in improving mastitis traits in dairy cattle.
The search for genetic markers of mastitis traits for use in selection programs has
focused on identification of QTLs and candidate genes. As of March 2017, the cattle
QTL database (http://animalgenome.org/cgi-bin/QTLdb/BT/index), which catalogues
publicly available QTLs in cattle [119], lists 244 distinct QTLs of mastitis traits. These
include 69 QTLs for clinical mastitis, 28 QTLs for SCC, and 147 QTLs for SCS.
Numerous candidate genes with recognized genetic variants have been proposed as likely
contributors to mastitis traits due to their roles in the pathogenesis of mastitis. Examples
of promising candidate genes proposed by multiple independent studies include C-X-C
motif chemokine receptor 1 (CXCR1) [120–127], TLR4 [128–131], and TLR2 [132–
134]. C-X-C motif chemokine receptor 1 is a high-affinity receptor for IL-8. Receptorligand interaction promotes cell migration, production of reactive oxygen species, and
phagocytosis, and affects cell survival regulation and cytokine production [135].
Significant upregulation of CXCR1 expression occurs rapidly in the bovine mammary
gland following intramammary infusion of bacteria [136]. Toll-like receptors 2 and 4 are
involved in pathogen recognition [6], and are upregulated in the bovine mammary gland
during mastitis [137].
Before any selection method, including marker-assisted selection, is implemented, the
effects of selection on other traits must be considered. In some instances, selection for a
single trait can have detrimental effects on the selection progress of separate traits [117].
For example, an unfavorable genetic correlation for mastitis traits and milk production
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traits has been demonstrated [93,138,139]. Linkage disequilibrium between causal
variants of these two traits exists in some regions of the genome, with common
haplotypes containing unfavorable alleles for one trait and favorable alleles for the other
[138,140]. Because these two traits are both considered important in dairy cattle, care
should be taken not to unacceptably compromise one trait for improvement of the other.
However, selection for both traits simultaneously is possible by, for example, selecting
for less common haplotypes that confer favorable alleles for both traits [140,141].
The identification and validation of genetic markers of mastitis traits, as well as their
implementation in selective breeding programs, are not without challenges. Genomewide association studies provide a powerful tool for discovery of genetic markers and
QTLs, but results must be repeatable for validation of true associations [114].
Identification of candidate genes can serve as a guide for follow-on studies to define the
functional relevance of variants and can advance knowledge of disease pathogenesis.
Additionally, in applying marker-assisted techniques to livestock improvement, the
effects of selection for a single trait on other important health or production traits must be
considered.

Research Objectives and Findings
The first objective of this dissertation was to identify QTLs of mastitis resistance
based on SNPs in Holstein dairy cattle. Phenotypic characterization of lactating Holstein
cattle was based on monitoring for clinical mastitis and milk bacterial culture,
supplemented by monthly SCC measurements, over an eight-month period. Phenotypic
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extremes (highly mastitis-resistant cattle and highly mastitis-susceptible cattle) were
identified and included in a GWAS using a selective genotyping approach. Using a
SLMM analysis, 117 SNPs suggestive of genome-wide significance (p<1E-04) for
mastitis resistance were identified. From these, 27 QTLs, including 10 novel QTLs, of
mastitis resistance were identified.
The remaining objectives of this dissertation involved assessment of bovine MEC
inflammatory responses. In order to accomplish these objectives, a method to establish
primary bovine MEC lines from a small volume of bovine milk was developed. The first
objective was to compare expression of inflammatory genes between bMECs from
mastitis-resistant cows, before and after stimulation of an inflammatory response, to
those of bMECs from mastitis-susceptible cows. The expression of genes relevant to
inflammation by unchallenged and LPS-challenged bovine MECs from mastitis-resistant
and mastitis-susceptible cattle were identified. An enhanced ability of bovine MECs from
mastitis-resistant cattle over those from mastitis-susceptible cattle to rapidly respond to
LPS challenge by differential expression of inflammatory genes was demonstrated.
Secondly, the expression of pro-inflammatory genes by unchallenged and LPSchallenged bovine MECs and bovine fibroblasts was compared, and a similar expression
pattern of interleukin 1 beta between the two cell types but a divergent expression pattern
of C-C motif chemokine ligand 20 was demonstrated. Next, the effect of exogenous
phospholipase A2 (PLA2), an enzyme involved in inflammatory mediator generation, on
the expression of pro-inflammatory genes by unchallenged and LPS-challenged bovine
MECs was examined. It was determined that PLA2 influences bMEC pro-inflammatory
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gene expression in response to LPS challenge but does not influence constitutive
expression. Finally, a milk-derived primary bovine MEC line with an extended capacity
for division through transfection with simian virus 40 large T antigen was established.
This cell line, as well as the methods used in its establishment, may be used to facilitate
future studies that require large numbers or extended growth of primary bMECs.
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CHAPTER 2
A GENOME-WIDE ASSOCIATION STUDY FOR MASTITIS RESISTANCE IN
PHENOTYPICALLY WELL-CHARACTERIZED HOLSTEIN DAIRY CATTLE
USING A SELECTIVE GENOTYPING DESIGN

Abstract
Background
A decrease in the incidence of bovine mastitis, the costliest disease in the dairy industry,
can be facilitated through genetic marker-assisted selective breeding programs.
Identification of genomic variants associated with mastitis resistance is an ongoing
endeavor for which genome-wide association studies (GWAS) using high-density arrays
provide a valuable tool.

Results
We identified single nucleotide polymorphisms (SNPs) in Holstein dairy cattle associated
with mastitis resistance in a GWAS by using a high-density SNP array. Mastitis-resistant
(15) and mastitis-susceptible (28) phenotypic extremes were identified from 224 lactating
dairy cows on commercial dairy farm located in Utah based on multiple criteria of
mastitis resistance over an 8-month period. Twenty-seven quantitative trait loci (QTLs)
for mastitis resistance were identified based on 117 SNPs suggestive of genome-wide
significance for mastitis resistance (p<0.0001), including 10 novel QTLs. Seventeen
QTLs overlapped previously-reported QTLs of traits relevant to mastitis, including four
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QTLs for teat length. One QTL includes the RAS guanyl releasing protein 1 (RASGRP1)
gene, a candidate gene for mastitis resistance.

Conclusions
This GWAS identifies 117 candidate SNPs and 27 QTLs for mastitis resistance using a
selective genotyping approach, including ten novel QTLs. Based on overlap with
previously-identified QTLs, teat length appears to be an important trait in mastitis
resistance. The RASGRP1 gene, overlapped by one QTL, is a candidate gene for mastitis
resistance.

Key words
Genome-wide association study; bovine mastitis resistance; selective genotyping; cattle

Background
Mastitis, defined as inflammation of the mammary gland, is the costliest disease
in the dairy industry [1,2]. In the United States, the cost of bovine mastitis is estimated at
a value of approximately 10% of total milk sales [89]. Associated costs include loss of
production, decreased milk quality, discarded milk, labor, veterinary treatments, mastitisrelated culls, diagnostics, and preventative measures [3].
Conventional methods to reduce the incidence of mastitis within a herd
encompass both management practices and selection for mastitis-resistant phenotypes.
Recent technical advancement in cattle genomics, such as genome-wide association
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studies (GWAS), has led to the identification of quantitative trait loci (QTLs) associated
with mastitis traits [75,142,143]. Genetic selection for mastitis resistance traits provides a
valuable tool for decreasing mastitis incidence. Genetic marker-assisted selection for
mastitis traits results in a higher level of discrimination between phenotypes and a greater
uniformity than does conventional selection [94], highlighting the importance of
identifying robust genetic markers for mastitis resistance. Genome-wide association
studies are well-suited to identifying genetic markers of complex traits such as mastitis,
enabling genotyping of large numbers of potential genetic markers, such single
nucleotide polymorphisms (SNPs), across the genome [98,99]. Indeed, GWAS carried
out over the past several years have identified genetic markers, candidate genes, and
QTLs for individual mastitis traits such as somatic cell count (SCC), somatic cells score
(SCS) and clinical mastitis [142,144,145]. Many of these studies use low- or mediummarker density arrays to detect genetic markers [75,145,146]. High-density bovine arrays
capable of genotyping close to one million SNPs are available for cattle and offer the
advantage of increased genomic coverage and statistical power [144]. Studies using such
high-density arrays have the potential to identify novel genetic markers as well as verify
the significance of previously identified markers.
In this study, we performed a GWAS using a high-density array to identify SNP
genetic markers and define QTLs of mastitis resistance in Holstein dairy cows. We used a
selective genotyping approach, identifying the most mastitis-resistant and mastitissusceptible animals within the sample population. This approach facilitated detection of
causative alleles due to an enrichment effect of these alleles among phenotypically
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extreme individuals [104]. Phenotypic characterization was based on multiple criteria of
intramammary infection status in order to achieve more accurate characterization of
phenotypic extremes of mastitis resistance and mastitis susceptibility than could be
achieved with use of a single measure of mastitis alone.

Methods
The aim of this study is to identify SNP genetic markers and QTLs of mastitis
resistance in dairy cattle. A genome-wide association study was performed using a
selective genotyping approach.

Selection of phenotypically extreme cattle
Cattle used in the study were adult lactating Holstein cattle from a single farm,
and phenotypically extreme individuals of mastitis resistance and mastitis susceptibility
were identified and selected for genotyping. Phenotypic characterization was based on a
combination of milk bacterial culture, observation for clinical mastitis, and SCC
evaluation over an eight-month period. Subclinical mastitis was defined as cases in which
intramammary infection was detected by bacterial culture of milk but no changes were
detected in the appearance of the mammary gland or milk. Clinical mastitis was defined
as intramammary infection accompanied by clinically detectable inflammatory changes
in the mammary gland and/or changes in the consistency or color of the milk.
To detect of clinical and subclinical mastitis, monthly bacterial cultures were
performed by using aseptically collected composite milk samples. Milk microbial culture
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was carried out according to the guidelines outlined by the National Mastitis Council
[147]. Isolation of at least one bacterial colony from a 0.01 ml inoculum of a single milk
culture sample was considered sufficient to diagnose intramammary infection, as
proposed by the Mastitis Research Workers [71]. Detection of clinical and subclinical
mastitis was also based on bi-monthly veterinary clinical evaluations to detect abnormal
mammary gland quarters or secretions; continuous monitoring for clinical mastitis by
farm staff; and individual quarter bacterial culture of milk from suspect intramammary
infection cases at the time of detection. Monthly SCCs were used as supplementary
evidence for the absence of intramammary infection in animals from which no bacteria
were isolated from milk samples and no clinical mastitis was detected. Monthly SCC
measures were obtained from the Dairy Herd Improvement Association (DHIA).
Chronic (continuing) cases of clinical and subclinical mastitis were distinguished
from new cases on the basis of time elapsed between detection of sequential episodes,
time elapsed after treatment from a previous episode, quarter(s) affected, and etiologic
agent [148–150]. For the purposes of this study, cattle with multiple new episodes of
mastitis were selected as mastitis-susceptible over those with few but chronic episodes.
Criteria for classification as mastitis-resistant included an absence of clinical mastitis, an
absence of bacteria cultured from milk samples throughout the eight-month period, and
consistently low SCCs (<250,000 cells/ml). The criterion for classification as mastitissusceptible was detection of at least four separate episodes of mastitis. Episodes of
mastitis were defined by any of: isolation of one or more mastitis pathogens from a milk
sample, detection of clinical mastitis, and/or elevated composite SCC >250,000 cells/ml.
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Isolates from more than one quarter on one date contributed as many mastitis episodes as
there were culture-positive quarters. Clinical mastitis detected in more than one quarter
on one date contributed as many mastitis episodes as there were clinically mastitic
quarters.

DNA isolation
Genomic DNA of cows characterized as mastitis-resistant or mastitis-susceptible
was isolated from ear notches or hair follicles. Isolation and purification of DNA was
carried out using the Gentra Puregene Tissue Kit (Qiagen, Valencia, CA) according to the
manufacturer’s instructions.

SNP genotyping
Genotype calling was carried out by the Core Facility at the University of Utah for
SNP genotyping using the Illumina BovineHD BeadChip (part # WG-450-1002; Illumina
Inc., San Diego, CA), an array with 777,962 SNPs that uniformly span the entire bovine
genome. Bead chips were processed according to the Infinium protocol from Illumina,
and scanning carried out by the iScan scanner (Illumina Inc., San Diego, CA). Quality
control measures included removal of animals with low call rates (<96%), SNPs with low
call rates (<0.95), and SNPs with low minor allele frequencies (<5%).
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Statistical analysis
Significant associations between SNPs and mastitis resistance were detected using
a single locus mixed model approach as implemented by the SNP and Variation Suite
software (SVS version 8.4, Golden Helix, Bozeman, MT). Familial relatedness was
corrected for as a random effect by incorporation of a genomic best linear unbiased
prediction (gBLUP) kinship matrix [107] into the model, constructed from genome-wide
SNPs after pruning for linkage disequilibrium (LD). Genome-wide association mapping
used a mixed linear model analysis [110] using the gBLUP matrix to correct for cryptic
relatedness, with mastitis resistance/susceptibility coded as a binary phenotype. A
genome-wide suggestive threshold was set at an uncorrected p-value of p < 0.0001, with
p < 0.001 considered nominal.

Defining QTLs
Quantitative trait loci were defined as described previously [142]. A QTL
surrounding each SNP detected as significant (p < 0.0001) was defined based on local LD
structure. Pairwise LD between the target SNP and all individual genotyped SNPs within
1 Mb upstream and downstream was calculated using PLINK [151]. Within this region,
visualized using the ggplot function of the R Studio statistical package [152], the furthest
upstream and downstream SNPs in strong LD with the target SNP (r2 ≥ 0.8) were used to
define QTLs. Quantitative trait loci comprised of a single SNP only were excluded.
Overlapping QTLs were combined into a single QTL, defined by the furthest upstream
and downstream SNPs for the combined region. Once defined, QTLs were aligned to the
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bovine genome (Bos_taurus_3.1.1/bosTau8 assembly; [153]) using the University of
California Santa Cruz (UCSC) Genome Browser tool (https://genome.ucsc.edu/) and
dbSNP [154] to identify genes overlapping these regions. These QTLs were checked for
overlap with known bovine QTLs using the cattle QTL database
(http://animalgenome.org/cgi-bin/QTLdb/BT/index) as of April 2017 [155].

Results
Sample population
Mastitis-resistant and mastitis-susceptible cows in a commercial dairy herd with
224 lactating Holstein cows were identified following monitoring for clinical and
subclinical mastitis over an eight-month period. From this rigorous mastitis-screening
program, 15 animals were characterized as mastitis-resistant (Table 1A) and 28 animals
as mastitis-susceptible (Table 1B). All mastitis-susceptible cows with the exception of
one had four confirmed cases of mastitis. One cow had three cases of mastitis confirmed
by isolation of three separate pathogens, and one tentative case where sample
contamination precluded definitive pathogen isolation. Cattle within the mastitis-resistant
group ranged from second to sixth lactation, and cattle within the mastitis-susceptible
group ranged from first to sixth lactation. Among the mastitis-resistant group, individual
composite milk SCCs over the eight-month period ranged from 5,000 to 220,000
cells/ml, with an average of 56,300 cells/ml. Among the mastitis-susceptible group, the
number of clinical mastitis episodes ranged from none to three. Individual quarter and
composite milk SCCs ranged from 6,000 to 2,676,000 cells/ml, with an average of
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303,000 cells/ml. Commonly isolated bacterial species from composite and individual
quarter milk samples from mastitis-susceptible cattle included coagulase-negative
staphylococci, Streptococcus sp., Corynebacterium sp., and Escherichia coli.

Genome-wide associations
In order to identify SNP genetic markers and QTLs of mastitis resistance, we
carried out a GWAS using a selective genotyping approach. Of 224 lactating Holstein
dairy cows, we selected the top 15 most mastitis-resistant and the top 28 most mastitissusceptible cows for genotyping.
Following data quality control measures, 585,949 SNPs remained for association
testing using data from 43 animals (28 mastitis-susceptible, 15 mastitis-resistant),
represented in Figure 1A as a Manhattan plot. Based on deviation from a linear
relationship between observed and expected p-values, as illustrated in Figure 1B in a
quantile-quantile plot, a p-value threshold of 0.0001 was set as suggestive of genomewide significance and a p-value of > 0.0001, ≤ 0.001 was considered nominal for
association.
One hundred and seventeen SNPs were suggestive of genome-wide significance
(Table 2). Based on these 117 SNPs, we identified 27 QTLs of mastitis resistance,
distributed across 14 chromosomes (2, 3, 7, 8, 10, 11, 12, 15, 16, 17, 18, 26, 27, and 28)
and overlapping a total of 29 genes (Table 3). Of these QTLs, 10 have not been reported
previously. Thorough phenotypic characterization using both direct (clinical mastitis and
milk bacterial culture) and indirect (SCC) measures to detect mastitis over an eight-
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month period, as well as use of a selective genotyping approach, facilitated identification
of these 10 novel QTLs.
The three QTLs most highly suggestive of genome-wide significance (-log10(pvalue) ≥ 5.41) are located on Bos taurus autosome (BTA) 26 and overlap the sortilin
related VSP10 domain containing receptor 3 (SORCS3) gene as well as a previouslyidentified QTL for teat length. The SORCS3 gene has no known function in bovine
mastitis. Another QTL suggestive of genome-wide significance overlaps the RAS
guanyl-releasing protein 1 (RASGRP1) gene, a candidate gene for mastitis resistance.
Seven hundred and sixty-three SNPs were nominal for genome-wide significance (Table
12, Appendix), distributed across all autosomal and the X chromosome.
Seventeen of the QTLs we identified overlap with previously identified QTLs of
mastitis traits (somatic cell score, SCC, and clinical mastitis) and/or udder conformation
traits (teat length, teat number, udder attachment, and udder depth; Table 4). Our findings
reinforce the discovery of these 17 QTLs and provide supporting evidence that these
QTLs may influence mastitis resistance. The top 3 QTLs overlap with a known QTL for
teat length, which may provide the basis of mastitis resistance at these regions.

Discussion
We carried out a GWAS using a selective genotyping approach and a high-density
bovine SNP array, and identified 117 SNPs suggestive of genome-wide association for
mastitis resistance in Holstein dairy cattle. Based on these 117 SNPs, we identified 27
QTLs of mastitis resistance, including 10 novel QTLs.
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The RASGRP1 gene is located within a QTL we identified on BTA10, defined by
8 SNPs genotyped in our GWAS. RASGRP1 is involved in the regulation of lymphocyte
development, activation, and function and in T-cell receptor signaling [156]. Differential
expression of RASGRP1 as a result of pathogen challenge occurs in primary bMECs
[157] and in ovine milk somatic cells [156], indicating a potential role in mastitis in
ruminants. Overlap of RASGRP1 by one of the QTLs indicates this gene as a strong
candidate for mastitis resistance, warranting further investigation.
In dairy cattle, both immune functions and udder conformation traits are
recognized factors affecting mastitis resistance [158]. Udder attachment and udder depth
have been associated previously with SCC and clinical mastitis [159,160]. Teat
placement has been associated with SCC [160], and various studies show conflicting
results of the association between teat length and SCC and clinical mastitis [161]. The
presence of supernumerary teats is considered a risk factor in bovine mastitis, and their
surgical removal may affect subclinical mastitis incidence in heifers [162]. Seventeen
QTLs that overlap with previously identified QTLs of udder conformation traits (teat
length, teat number, udder attachment, and udder depth) as well as mastitis traits (somatic
cell score, SCC, and clinical mastitis) were identified. Overall, 11 of these 17 QTLs
overlap with QTLs for mastitis traits, and 13 overlap with QTLs for udder conformation
traits.
Ten of these 17 QTLs overlap with previously identified QTLs for teat length. Six
of these, including the top 3 where the strongest association signals were detected overall,
are located on BTA26 and overlap with a single previously-identified QTL for teat length
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[158]. The remaining overlap with QTLs for teat length on BTA16 [158], BTA18 [163],
and BTA10 [163]. This finding provides strong supportive evidence for an effect of teat
length on bovine mastitis resistance, highlighting the importance of udder conformation
traits as factors in the pathogenesis of this disease.
A notable strength of this study lies in the methods used for phenotypic
classification, wherein multiple measures were used to determine intramammary
infection status over time and identify mastitis-resistant and mastitis-susceptible
phenotypic extremes. The effectiveness of selection for mastitis resistance increases
when more than a single trait is measured for determination of intramammary infection
status. For example, the use of SCC and clinical mastitis together is approximately 20%
more effective than the use of either of these traits alone in selecting for mastitis
resistance [164,165]. The use of multiple measures to detect mastitis helps to overcome
limitations of any one method. For example, patterns of bacterial shedding in milk during
the course of infection may affect the sensitivity of milk bacterial culture to detect
intramammary infection [166]. Examination for clinical mastitis alone by definition
excludes cases of subclinical mastitis, potentially excluding a substantial number of
intramammary infections from being detected. Indirect measures such as SCC or its
derivatives (linear score and estimated breeding values for these traits) can be influenced
by a number of management and cow-dependent factors such as immune status, parity,
lactation stage, diurnal variation, and sudden changes in feed or water management
[62,65,167]. Additionally, although low SCC is commonly accepted as indicative of an
absence of intramammary infection, some studies have demonstrated low SCC as a risk
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factor in the subsequent development of clinical mastitis [67,68]. Thus, the use of SCC to
indicate mastitis resistance could be misleading in some cases if not supplemented by
additional measures.
In consideration of the above limitations, phenotypic characterization was based
on multiple criteria in order to accurately identify phenotypic extremes of mastitis
resistance and susceptibility. Reliable determination of intramammary infection status is
best achieved through a combination of SCC measurement, bacterial culture, and clinical
detection [71], as used in this study. Regular monitoring using these three parameters
facilitates detection of clinical and subclinical mastitis, including infections resulting in
minor increases in SCC. Additionally, identification of the causative bacteria allows
distinction between continuing and new intramammary infections, yielding a more
accurate picture of the frequency of intramammary infection in individual cows (i.e.,
whether increased SCC or clinical mastitis over time represents an ongoing infection or
multiple separate infections).
All cows within the current study were within the same herd and were subjected
to the same management conditions. Thus, effects of environmental variables on mastitis
susceptibility are expected to be low relative to studies in which cattle from different
farms and thereby under different environmental and management conditions are
included. Identification of 10 novel QTLs of mastitis resistance was likely facilitated by
particularly stringent phenotypic characterization methods and sample population
selection.
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A potential limitation to the current study is the relatively small sample size. Out
of 224 lactating cows, 43 were characterized as phenotypic extremes for mastitis
resistance or susceptibility. In GWAS, sample size is one of the factors influencing
statistical power, and sample sizes in the thousands are often used [96]. In this study,
meticulous phenotypic characterization was chosen at the expense of large sample size in
order to identify individual cattle representative of phenotypic extremes. Genotyping only
individuals that represent phenotypic extremes for a trait (no more than 20-25% of the
sample population) can be used to detect QTLs for single traits among a small sample
size while preserving statistical power in a selective genotyping approach [103,168]. Out
of 224 cows, only the highest and lowest extremes for mastitis resistance of the
population at 6.7% and 12.5%, respectively, were genotyped. The use of selective
genotyping provides an enrichment effect, as causal and protective variants are more
likely to be concentrated in these individuals as compared with individuals sampled
randomly from the population. Thus, the power to detect causal and protective variants,
particularly rare variants, is increased, although the effect size will be overestimated
[104]. Follow-on studies to replicate results are therefore important [104]. We believe
that, in addition to phenotypic characterization methods, the use of selective genotyping
along with a high-density SNP array facilitated identification of the 10 novel QTLs.

Conclusions
One hundred seventeen candidate SNPs and 27 QTLs for mastitis resistance
within a population of phenotypically well-characterized dairy cattle were identified. The
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three QTLs most suggestive of genome-wide significance are located on BTA26 and
overlap SORCS3 and a previously identified QTL for teat length. Ten of the 27 QTLs
have not been reported previously, while 17 overlap previously identified QTLs for
mastitis or udder conformation traits relevant to mastitis. One QTL on BTA10 overlaps
RASGRP1, considered a candidate gene of mastitis resistance requiring further study.
Validation of these QTLs as genetic markers of mastitis resistance in an expanded
population is required.

50
Table 1A: Lactation number and phenotypic classification data for mastitis-resistant
cows.
Lactation
Number

Mean SCC,

SCC Range,

x1000 cells/ml

x1000 cells/ml

Clinical Mastitis
Episodes

Pathogens Isolated

2

24.7

16-33

0

None

6

57.8

32-84

0

None

5

84.5

22-155

0

None

4

48.0

21-125

0

None

4

31.3

16-50

0

None

3

86.3

20-150

0

None

3

69.7

21-123

0

None

3

70.5

19-107

0

None

3

40.5

5-61

0

None

3

21.4

9-47

0

None

2

23.8

20-29

0

None

2

100.3

35-167

0

None

2

15.0

5-27

0

None

2

33.6

9-69

0

None

2

123.0

30-220

0

None
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Table 1B: Lactation number and phenotypic classification data for mastitis-susceptible
cows.
Clinical
Mastitis
Episodes

Pathogens1 Isolated
(Number of Times)

Lactation
Number

Average SCC,

SCC Range,

x1000 cells/ml

x1000 cells/ml

2

519.7

21-2406

1

CNS (2); CNS and St (2)

6

217.6

146-1327

0

CNS (1); St (2): CNS and St (3)

4

136.1

88-197

0

CNS (1); C (1); Y (1)

4

617.3

8-1464

3

St (2); CNS and St (1); C and St (3)

3

298.3

120-622

0

CNS (4); CNS and St (2)

4

477.4

86-1899

0

CNS (5); CNS and E (1)

4

391.0

210-868

2

CNS (2); CNS and St (3)

3

463.0

270-591

2

St (6)

3

1292.7

401-2945

0

CNS (2); CNS and St (4); E and St (1)

3

144.2

26-332

0

St (4)

2

49.0

16-84

0

CNS (5); CNS and C (1)

2

704.6

6-1605

0

CNS (2); St (5)

2

154.0

14-937

0

CNS (1); CNS and St (2); C (1)

2

258.8

9-981

3

CNS and St (1); St (1); C (2); E (1)

2

20.3

10-30

0

CNS (2); C and St (1); C (1)

2

81.0

10-248

1

CNS (1); CNS and St (2); CNS and C (1)

1C:

1

33.7

7-58

0

CNS (2); CNS and St (2); CNS and C (1)

1

108.9

55-191

0

CNS (5)

1

60.0

48-88

0

CNS (4); E (1)

1

112.9

76-139

0

CNS (6)

1

32.0

17-58

0

CNS (4)

1

97.3

55-238

0

CNS (5)

1

129.4

79-287

0

CNS (4)

2

615.2

13-2676

1

CNS (4); Y (1)

1

43.3

27-74

0

CNS (3); St (1)

1

197.0

35-568

0

CNS (5); CNS and St (1)

1

18.1

7-33

0

CNS (3); C (2)

1

115.4

60-175

1

CNS (2); St (2); CNS and St (1)

Corynebacterium sp.; CNS: coagulase-negative staphylococci; E: Escherichia coli; St: Streptococcus
sp.; Y: yeast.
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Table 2: Single nucleotide polymorphisms suggestive of genome-wide significance for
bovine mastitis resistance. The allele associated with mastitis resistance is shown.
Marker

Chr1

Position

-log10(p-value)

Protective allele

rs43503386

7

31648926

6.33

A

rs110130285

26

26080988

5.81

G

rs110925919

26

26081853

5.81

T

rs135137805

26

26083915

5.81

C

rs109051904

26

26085037

5.81

A

rs134424973

26

26086114

5.81

G

rs136355517

26

26202415

5.55

A

rs137057269

26

26207987

5.55

G

rs109151150

7

31002352

5.51

T

rs135679846

26

26213600

5.42

C

rs136832332

26

26214187

5.42

T

rs135349914

26

26216213

5.42

C

rs135745332

26

26170699

5.41

C

rs29026516

26

26171235

5.41

G

rs133973225

26

26190210

5.41

A

rs42094305

26

26078080

5.14

C

rs42094275

26

26097110

5.14

C

rs110448143

8

103092247

4.98

G

rs110566862

8

103096670

4.98

T

rs134258818

26

26093838

4.92

T

rs109674792

17

41771455

4.85

G

rs110306521

17

41773340

4.85

A

rs109747092

17

41775569

4.85

C

rs110239244

17

41777130

4.85

C

rs109757388

17

41785932

4.85

G

rs41837662

26

28202019

4.80

T

rs109555679

24

53848687

4.73

C

rs41257394

18

49690172

4.64

A

rs110711227

15

47742405

4.57

A

rs109993951

15

47747052

4.57

A

rs137210653

15

47752356

4.57

C

rs109366311

15

47769743

4.57

C

rs110973322

15

47771595

4.57

A

rs110039012

15

47774554

4.57

C

rs110259421

15

47775426

4.57

C

53
rs136099077

7

32661575

4.55

G

rs133992636

7

32662549

4.55

G

rs135340284

7

32667624

4.55

A

rs29016545

7

32677080

4.55

T

rs134516100

7

32678638

4.55

T

rs41836660

26

28154738

4.55

C

rs41604819

26

28155692

4.55

T

rs41837669

26

28204944

4.55

G

rs133596831

16

20614247

4.48

C

rs133973886

2

118870124

4.47

T

rs41858359

18

5268101

4.44

T

rs41858365

18

5268998

4.44

T

rs109361888

26

26164774

4.42

T

rs135248266

9

93691403

4.42

C

rs135549815

15

51302501

4.40

C

rs136596564

15

51303719

4.40

C

rs110825365

17

41777826

4.37

A

rs137547715

3

91427052

4.35

T

rs136877205

17

10393778

4.35

T

rs110090917

11

96629841

4.32

T

rs381266606

11

96715963

4.32

T

rs136634740

11

96720014

4.32

G

rs133879444

11

96730359

4.32

T

rs134973228

11

96734171

4.32

T

rs132794203

11

96739382

4.32

G

rs134297845

11

96745000

4.32

G

rs109277843

11

96758826

4.32

C

rs135608670

11

96767134

4.32

T

rs134694194

17

10162372

4.31

T

rs109623385

10

34452835

4.29

A

rs109758936

10

34455599

4.29

T

rs133303871

11

86660988

4.28

T

rs42434953

26

28796634

4.28

T

rs42434958

26

28799734

4.28

A

rs42434984

26

28813937

4.28

A

rs42349819

3

91442018

4.27

A

rs42349795

3

91449020

4.27

A

rs109782486

7

31997138

4.25

C

rs109397365

7

31999677

4.25

T

rs135897745

7

32000505

4.25

T

54
rs109305062

7

32001031

4.25

C

rs135287427

7

32001859

4.25

A

rs132918628

7

32002610

4.25

C

rs109653519

7

32003545

4.25

T

rs109153790

7

32004528

4.25

C

rs133045718

7

32005033

4.25

T

rs137193453

7

32005542

4.25

G

rs133716861

3

91429028

4.23

A

rs42704013

12

76820530

4.22

A

rs136350185

10

27915567

4.19

A

rs41840890

26

27751543

4.17

G

rs41840882

26

27754542

4.17

T

rs41840873

26

27756172

4.17

G

rs41840864

26

27762180

4.17

A

rs137165178

26

27763096

4.17

T

rs41840922

26

27779611

4.17

A

rs41840912

26

27790973

4.17

G

rs135563166

26

28157430

4.16

G

rs41636626

26

28159060

4.16

C

rs133999463

26

28159800

4.16

C

rs133395250

26

28161303

4.16

G

rs135413917

26

28161892

4.16

G

rs133282066

26

28163345

4.16

A

rs135170589

26

28165109

4.16

T

rs136506930

26

28165749

4.16

G

rs134913097

26

28167337

4.16

A

rs137741079

26

28168568

4.16

C

rs133840132

26

28170114

4.16

A

rs135204195

26

28172302

4.16

A

rs133679609

17

42208979

4.14

C

rs41645946

11

96814663

4.12

C

rs133086162

27

24405764

4.11

C

rs132797061

X

10123521

4.10

T

rs110373429

26

27935893

4.10

C

rs110554155

4

41207992

4.08

T

rs43506093

7

32187800

4.07

C

rs134956968

28

30879841

4.07

G

rs110413607

10

34258059

4.06

T

rs41668080

12

76870470

4.05

T

rs110442181

11

102314941

4.02

C

55
rs41879775

18

43568128

4.00

G

rs135753929

18

43596859

4.00

A

1Chr:

chromosome.

Table 3: Quantitative trait loci identified for bovine mastitis resistance. Overlapped genes are shown.
Chr

QTL start

QTL end

QTL length
(bp)

No. SNPs

Tag SNP

-log10(p-value)

No.
Genes

26
26
26
8
17
26
18
15
7
16
2
18
15
17
11
10
26
3
7
10
26
17
27
28
12
11
18

26078080
26202415
26170699
103092247
41733436
28154738
49684020
47742405
32661575
20608750
118870124
5268101
51068247
10393778
96629841
34258059
28796634
91429028
31997138
27798183
27751543
42046346
24405764
30834105
76826267
102314941
43568128

26097110
26216213
26190210
103096670
41785932
28204944
49690172
47775426
32678638
20623978
118870999
5268998
51303719
10411003
96777054
34455599
28813937
91852910
32005542
28002566
27790973
42208979
24803258
30879841
76870470
102336231
43596859

19030
13798
19511
4423
52496
50206
6152
33021
17063
15228
875
897
235472
17225
147213
197540
17303
423882
8404
204383
39430
162633
397494
45736
44203
21290
28731

7
5
3
2
10
15
2
7
5
12
2
2
3
2
11
8
3
4
10
31
7
7
2
8
3
8
5

rs110130285
rs136355517
rs135745332
rs110448143
rs109674792
rs41837662
rs41257394
rs110711227
rs136099077
rs133596831
rs133973886
rs41858359
rs135549815
rs136877205
rs110090917
rs109623385
rs42434953
rs42349819
rs109782486
rs136350185
rs41840890
rs133679609
rs133086162
rs134956968
rs41668080
rs110442181
rs135753929

5.8056407
5.5513441
5.4109618
4.9800087
4.851678
4.79832714
4.6439513
4.5675268
4.5538269
4.4783498
4.4696943
4.4439869
4.40396843
4.3453674
4.32303429
4.2941828
4.276744
4.27157104
4.2477407
4.1880203
4.1697935
4.13810535
4.1081123
4.07061418
4.0468275
4.0153069
4.00357851

1
1
1
0
1
1
2
1
0
1
1
0
1
1
1
2
0
1
1
3
0
0
1
2
2
3
3

Genes
SORCS3
SORCS3
SORCS3
None
FAM198B
SORCS1
FBL, PSMC4
OR52E4
None
ESRRG
FBXO36
None
LOC618050
ARHGAP10
PBX3
RASGRP1, LOC104973119
None
USP24
PRDM6
LOC784925, LOC785050, LOC785050
None
None
TNKS
MIR584-3, KAT6B
CLDN10, DZIP1
NTNG2, SETX, LOC101906746
FAAP24, RHPN2, CEP89
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Table 4: Overlap of QTLs for bovine mastitis resistance with previously-reported QTLs1 for bovine mastitis or udder conformation
traits.
Chr

QTL position (bp)

Tag SNP

-log10(p-value)

Known QTLs

26
26
26
8
17
26

26078080-26097110
26202415-26216213
26170699-26190210
103092247-103096670
41733436-41785932
28154738-28204944

rs110130285
rs136355517
rs135745332
rs110448143
rs109674792
rs41837662

5.8056407
5.5513441
5.4109618
4.9800087
4.851678
4.79832714

18

49684020-49690172

rs41257394

4.6439513

15
7
16
2
18

47742405-47775426
32661575-32678638
20608750-20623978
118870124-118870999
5268101-5268998

rs110711227
rs136099077
rs133596831
rs133973886
rs41858359

4.5675268
4.5538269
4.4783498
4.4696943
4.4439869

15
17
11
10

51068247-51303719
10393778-10411003
96629841-96777054
34258059-34455599

rs135549815
rs136877205
rs110090917
rs109623385

4.40396843
4.3453674
4.32303429
4.2941828

Teat length
Teat length
Teat length
None
Teat number
Udder attachment
Clinical mastitis
Teat length
Somatic cell score
Somatic cell score
Somatic cell score
Somatic cell score
Teat length
None
Somatic cell score
Teat length
None
Somatic cell score
Udder attachment
None
None
None
Udder attachment
Teat length
Udder attachment
Somatic cell score

Known QTL ID1

Known QTL position (bp)

1651
1651
1651

25267910-30988113
26:25267910-30988113
25267910-30988113

20841
4995
4994
1651
2785
2736
18471
18470
1703

34618653-44087629
27602977-30988113
27602977-30988113
25267910-30988113
27602977-30988113
27602977-30988113
46178647-52998234
46178647-52983181
44616854-55337025

2667
1608

27358606-42831622
12209667-26166559

3554
1701

4992421-18045667
1891819-7214579

10294
10296
44454
44457

10323420-79980762
10323420-79980762
34275633-34275673
34275633-34275673
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26

Chr26:2879663428813937

rs42434953

4.276744

3
7
10

91429028-91852910
31997138-32005542
27798183-28002566

rs42349819
rs109782486
rs136350185

4.27157104
4.2477407
4.1880203

26

27751543-27790973

rs41840890

4.1697935

17
27
28
12
11
18

42046346-42208979
24405764-24803258
30834105-30879841
76826267-76870470
102314941-102336231
43568128-43596859

rs133679609
rs133086162
rs134956968
rs41668080
rs110442181
rs135753929

4.13810535
4.1081123
4.07061418
4.0468275
4.0153069
4.00357851

1QTLs

Udder depth
Somatic cell count

44459
2701

34275633-34275673
22939631-40797089

Udder attachment

4995

27602977-30988113

Clinical mastitis
Teat length
Somatic cell score
Somatic cell score
None
Somatic cell score
Udder attachment
Teat length
Somatic cell count
Udder attachment
Clinical mastitis
Teat length
Somatic cell score
Somatic cell score
Teat number
Clinical mastitis
None
None
None
Somatic cell score
Somatic cell score

4994
1651
2785
2736

27602977-30988113
25267910-30988113
27602977-30988113
27602977-30988113

2667
10294
10296
2701
4995
4994
1651
2785
2736
20841
2786

27358606-42831622
10323420-79980762
10323420-79980762
22939631-40797089
27602977-30988113
27602977-30988113
25267910-30988113
27602977-30988113
27602977-30988113
34618653-44087629
24311474-24427274

9904
18469

33939994-43945245
11438802-46178647

as listed on the cattle QTL database (http://animalgenome.org/cgi-bin/QTLdb/BT/index).
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Figure 1A: Manhattan plot of genome-wide associations for mastitis resistance in 43 Holstein cows. The genome-wide significance
threshold is indicated by the solid line (p < 0.0001). Bovine chromosome position is shown on the x-axis. Strength of association for a
single-locus mixed model GWAS is shown on the y-axis.
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Figure 1B: Quantile-quantile plot of observed and expected p-values.
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CHAPTER 3
BOVINE MAMMARY EPITHELIAL CELLS FROM MASTITIS-RESISTANT AND
MASTITIS-SUSCEPTIBLE LACTATING HOLSTEIN COWS DISPLAY
DIFFERENTIAL EXPRESSION OF INFLAMMATORY GENES IN RESPONSE TO
LIPOPOLYSACCHARIDE

Abstract
Bovine mammary epithelial cells (bMECs) are the milk-producing cells of the
mammary gland, and are important contributors to innate immunity against
intramammary infection. As such, differences in their innate immune responses against
mastitis-causing pathogens may contribute to inherent differences in susceptibility to
mastitis among individual cattle. In order to understand the immunogenetics of mastitis
resistance conferred by bMECs, we carried out a gene expression polymerase chain
reaction (PCR) array to characterize and compare the expression of 84 genes relevant to
inflammation by bMECs isolated from mastitis-resistant and mastitis-susceptible
lactating cows in response to lipopolysaccharide (LPS) from Escherichia coli. Primary
bMEC lines were established from lactating Holstein cows characterized as mastitisresistant or mastitis-susceptible based on clinical mastitis incidence, milk bacterial
culture results, and monthly milk somatic cell counts (SCC) over an eight-month period.
Exposure to LPS for 6 hours in vitro stimulated two-fold or greater differential
expression of 43 genes (p<0.05) in bMECs from mastitis-resistant cows, but only one
gene in bMECs from mastitis-susceptible cows. These results suggest that the ability of

62
bMECs to respond rapidly to mastitis pathogens may be a mechanism by which bMECs
contribute to mastitis resistance. Among upregulated genes, chemokine (C-X-C motif)
ligand 5 (CXCL5) was upregulated in bMECs from both mastitis-resistant and mastitissusceptible cows, while chemokine (C-X-C motif) ligand 2 (GRO1) and interleukin 8
(CXCL8) were upregulated in bMECs from mastitis-resistant cows only. Tumor necrosis
factor (TNF) was among the genes downregulated in bMEC from mastitis-resistant cows.
In contrast, no significant differences in gene expression were noted between mastitissusceptible and mastitis-resistant bMECs under unchallenged conditions, indicating that
constitutive expression of inflammatory genes is unlikely to be a mechanism for mastitis
resistance mediated by bMECs.

Background
Bovine mastitis is a major source of economic loss in the dairy industry
worldwide. Strategies to reduce the prevalence of mastitis among dairy cattle are based
on management of environmental factors as well as selection for cattle with increased
resistance to mastitis. A genetic basis for between-cow variation in mastitis traits, such as
clinical mastitis and somatic cell count (SCC), is widely recognized and is reflected in the
use of estimated breeding values for these traits to guide selective breeding programs
[169]. Many quantitative trait loci (QTLs) for mastitis traits have been identified
(catalogued on the cattle QTL database, http://animalgenome.org/cgibin/QTLdb/BT/index; [155]), and genetic marker-based selection methods are
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increasingly recognized as valuable tools in reducing the prevalence of mastitis within
dairy herds. Cellular mechanisms underlying bovine mastitis resistance are complex,
involving multiple cell types and pathogen-specific immune responses [79], and remain
incompletely defined.
An important cell type involved in immune responses to intramammary infection
and mastitis resistance is the bovine mammary epithelial cell (bMEC). Bovine MECs are
the milk-producing cells of the mammary gland, and also have roles in innate immunity
through barrier functions, pathogen recognition, and production of inflammatory
mediators, including leukocyte chemotactic factors [30]. Primary bMECs have been used
as a model for studies of immune responses of the mammary gland [39,170,171]. In vitro
models based on epithelial cell culture provide several notable advantages over in vivo
systems for studying disease processes. In vitro systems allow for greater control over
environmental variables, and provide economic and ethical advantages over in vivo systems
[172]. Additionally, monoculture-based systems facilitate the study of the roles of individual
cell types in disease processes, whereas differentiation between the contributions of multiple
cell types in in vivo systems may present substantial challenges [170,172]. Epithelial
monoculture systems have been used extensively in the study of host-pathogen interactions
in infectious disease processes [172]. The capacity of primary bMECs to mount pathogenspecific immune responses has been clearly demonstrated [38,157,170,171,173]. Expression
of many inflammatory genes involved in these responses are also demonstrated in bMECs in
vivo in response to inflammatory stimuli, reflecting the usefulness of primary bMECs as a
model for the bovine mammary gland in mastitis studies [36,174,175].
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Variation in the immune responses of bMECs from different individual cows have
been demonstrated, including significant differences between the responses of bMECs
from mastitis-resistant and mastitis-susceptible cows. For example, when primary bMECs
isolated from animals classified as exhibiting high and low susceptibility to mastitis with
the QTL on Bos taurus autosome (BTA) 18 were challenged by mastitis pathogens,
differential expression of several key innate immune genes was observed, including Tolllike receptor 2, tumor necrosis factor-alpha, interleukin-8 (IL-8), IL-6, chemokine (C-C
motif) ligand 5, complement component C3, and lactoferrin [176]. In primary bMECs
isolated from mastitis-resistant cows, compared to those isolated from mastitis-susceptible
cows, a number of genes involved in leukocyte migration and acute-phase response
signaling were expressed earlier and at higher levels following pathogen challenge [157].
These studies indicate an important role of bMECs in mastitis resistance that warrants
further study.
The objective of this study was to compare immune responses of bMECs from
mastitis-resistant and mastitis-susceptible cows in order to identify potential contributions of
bMECs to mastitis resistance. The relative expression of 84 immune-related genes was
determined by polymerase chain reaction (PCR) array, and compared between the two cell
lines before and after challenge by lipopolysaccharide (LPS) from Escherichia coli.
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Methods
Cow characterization
Lactating Holstein cows were classified as resistant or susceptible to mastitis
based on individual incidence of clinical and subclinical mastitis over an eight-month
period. Detection of clinical and subclinical mastitis was based on monthly bacterial and
mycoplasma cultures of aseptically collected composite milk samples; bi-monthly
clinical evaluations to detect abnormal mammary gland quarters or secretions; continuous
monitoring for clinical mastitis by farm staff; bacterial culture of milk from suspect
intramammary infection cases; and monthly SCC measurements obtained from the Dairy
Herd Improvement Association. Milk microbial cultures were carried out according to the
guidelines outlined by the National Mastitis Council [147].
The criterion for classification as mastitis-susceptible was detection of at least
four separate episodes of mastitis. Episodes of mastitis were defined by any of: isolation
of one or more mastitis pathogens from a milk sample, detection of clinical mastitis,
and/or elevated composite SCC >250,000 cells/ml. Isolates from more than one quarter
on one date contributed as many mastitis episodes as there were culture-positive quarters.
Clinical mastitis detected in more than one quarter on one date contributed as many
mastitis episodes as there were clinically mastitic quarters. Cattle with no clinical mastitis
detected, consistently negative milk bacterial culture results, and consistently low
(<250,000 cells/ml) milk SCC were characterized as mastitis-resistant.
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Bovine MEC collection, isolation, and establishment
Primary bMEC lines were established from bovine milk. Four hundred milliliters
of hand-stripped milk were aseptically collected into an equal volume of collection media
consisting of Hank’s Balanced Salt Solution (Sigma-Aldrich, St. Louis, MO)
supplemented with penicillin (60 μg/ml), streptomycin (200 μg/ml), gentamycin (120
μg/ml), and nystatin (50 mg/L). Samples were transported on ice to the laboratory.
Bovine MEC isolation was carried out as previously reported [39,177], with some
modifications. Briefly, 400 ml of hand-stripped milk were subjected to a series of wash
and centrifugation steps (3000 rpm for 10 minutes each) followed by passage of the
resuspended cell pellet through a 100 µm pore size cell strainer to separate cell pellets
from debris and other milk components. Following a final centrifugation step, the cell
pellet was resuspended in 5 ml of growth media consisting of HuMEC Ready Medium
(Life Technologies, Grand Island, NY) supplemented with penicillin (60 μg/ml),
streptomycin (200 μg/ml), gentamycin (120 μg/ml), nystatin (50 μg/ml), and 10% fetal
bovine serum, and seeded into a T-25 culture flask. Cells were incubated at 38.5°C with
5% CO2. After 12-18 hours, media was exchanged for fetal bovine serum-free growth
media. Growth media was changed every 2-3 days thereafter.
Cells were passaged when confluency was reached using trypsin 0.05%/EDTA
0.02% (product 59417C, Sigma-Aldrich, St. Louis, MO). Cells were maintained to the
second to third passage, at which point LPS challenge was carried out.
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Cell lineage verification
Cell lines were evaluated at all passage numbers for the cobblestone morphology
typical of epithelial cells on monolayer culture. Epithelial lineage was verified using PCR
to detect expression of cytokeratin 8 (KER8) [178]. Primers were designed using
Primer3Plus (http://primer3plus.com/cgi-bin/dev/primer3plus.cgi) based on NCBI
reference sequence NM_001033610.1 and were as follows: forward primer
AATCAAGTATGAGGAGCTGC; reverse primer CATCCTTAACAGCCATCTCA.
Polymerase chain reaction conditions were as follows: initial denaturation at 98˚C for 30
seconds followed by 32 cycles of 98˚C for 10 seconds, 57 ˚C for 15 seconds, and 72˚C
for 30 seconds. Gel electrophoresis was used to confirm the presence of PCR product.
Sequencing of PCR product to confirm KER8 amplification was carried out by the Center
for Integrated Biotechnology, Utah State University (Logan, UT).

LPS challenge and RNA isolation
Second to third passage bMECs were exposed to LPS from Escherichia coli
0111:B4 (Sigma-Aldrich, St. Louis, MO) to mimic exposure to a mastitis-causing
pathogen. Lipopolysaccharide challenge methods were similar to those described
previously [173]. Briefly, bMECs were split after the first or second passage into two T25 culture flasks. Once 50-100% confluence was reached, media was exchanged for
growth media with or without (unchallenged) 50 µg/ml LPS. Cells were incubated at
culture conditions for 6 hours, after which media was removed.
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Following LPS challenge, bMECs were lysed and total RNA was isolated and
purified using the Purelink RNA Mini Kit (Life Technologies, Carlsbad, CA) according
to the manufacturer’s instructions. Spectrophotometric verification of RNA quality and
generation of cDNA was carried out by QIAGEN Genomic Services (Frederick, MD).

PCR Array
The QIAGEN RT2 ProfilerTM PCR Array Cow Inflammatory Cytokines and
Receptors array (product PABT-011Z, QIAGEN, Frederick, MD) was used to profile the
expression of 84 genes involved in inflammation. Gene expression profiling and data
analysis were carried out by QIAGEN Genomic Services (Frederick, MD). The deltadelta CT method was used for fold-change/regulation analysis, with data normalized
using four internal control genes (glyceraldehyde-3-phosphate dehydrogenase; actin,
beta; hypoxanthine phosphoribosyltransferase 1; tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein, zeta polypeptide). P-values were calculated using a
Student’s t-test of the replicate 2^ (- Delta CT) values for each gene in the groups being
compared. Fold change/regulation values and p-values were generated for comparison of
the following groupings: 1) unchallenged and LPS-challenged mastitis-resistant bMEC
lines; 2) unchallenged and LPS-challenged mastitis-susceptible bMEC lines; and 3)
unchallenged mastitis-resistant and mastitis-susceptible bMEC lines.
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Results
Sample population
Bovine MEC lines were established from five mastitis susceptible and three
mastitis resistant cattle. Cattle within the mastitis-resistant group ranged from second to
third lactation, and cattle within the mastitis-susceptible group ranged from second to
sixth lactation. All bMEC lines were morphologically consistent with epithelial cells and
expressed KER8.
Among the mastitis-resistant group, composite milk SCC ranged from 16,000 to
220,000 cells/ml, with an average of 75,000 cells/ml. Among the mastitis-susceptible
group, pathogens isolated from composite and individual quarter milk samples included
Streptococcus sp., coagulase-negative staphylococci, and Corynebacterium sp. In this
group, composite milk SCC ranged from 14,000 to 2,406,000 cells/ml, with an average of
290,000 cells/ml.

PCR Array
Bovine MECs from mastitis-resistant and mastitis-susceptible cows respond to
LPS differently. Gene expression following LPS challenge varied between mastitissusceptible and mastitis-resistant bMEC lines. Among mastitis-resistant cell lines, three
genes, C-X-C motif chemokine ligand 5 (CXCL5), chemokine (C-X-C motif) ligand 2
(GRO1), and interleukin 8 (CXCL8), were significantly (p < 0.05) upregulated by at least
two-fold, while 40 genes were significantly downregulated by at least two-fold in LPSchallenged versus unchallenged bMEC lines (Table 5). Among the latter, complement
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component 5 (C5), chemokine (C-C motif) receptor 5 (CCR5), and interleukin 13 (IL13)
showed the highest magnitudes of downregulation, at -18.93-fold, -18.89-fold, and 18.74-fold, respectively. In contrast to the mastitis-resistant group, among mastitissusceptible bMEC lines, only one gene, CXCL5, was differentially expressed as a result
of LPS challenge. C-X-C motif chemokine ligand 5 was upregulated by 8.25-fold in LPSchallenged versus unchallenged bMECs. Upregulation of CXCL5 in both mastitisresistant and mastitis-susceptible bMECs following LPS challenge suggests that this is a
particularly important gene involved in the innate immune response of bMECs. A lack of
differential expression of additional genes among mastitis-susceptible bMECs following
LPS challenge contrasts with the differential expression of 42 additional genes by
mastitis-resistant bMECs. This finding indicates inherent differences in the immune
response capabilities of bMECs from the two groups.

Mastitis-resistant and -susceptible bMECs show similar expression under
unchallenged conditions. Gene expression between the mastitis-susceptible and mastitisresistant groups were investigated under unchallenged conditions. No genes were
significantly differently expressed between these two groups (Table 6). Such data
indicate that bMECs isolated from mastitis-resistant and -susceptible cows, while
displaying distinct gene expression patterns in responding to LPS, have similar innate
immune activities under unchallenged conditions. Therefore, it is likely that the
contribution of bMECs to mastitis resistance depends on their capability of mounting
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successful innate immune responses to mastitis pathogens, but not on the basal level
activities of the inflammatory genes.

Discussion
The objective of this study was to investigate the molecular and cellular
mechanisms by which bMECs contribute to mastitis resistance. To accomplish this, we
established multiple bMEC lines from mastitis-resistant and mastitis-susceptible cows
and compared the expression profiles of genes relevant to inflammation between these
two groups of bMECs using the QIAGEN’s RT2 ProfilerTM PCR Array before and after
LPS challenge.
No significant differences in gene expression between mastitis-resistant and
mastitis-susceptible bMECs under unchallenged conditions were observed. This is in
agreement with other studies that demonstrate no significant differences in the expression
of genes relevant to inflammation between bMECs from mastitis-susceptible and
mastitis-resistant cattle under unchallenged conditions [118,157]. Such data suggest that
constitutive expression of genes relevant to inflammation does not drive contributions of
bMECs to mastitis resistance.
In contrast, expression of genes related to inflammation differed between mastitisresistant and mastitis-susceptible bMECs following LPS challenge. Three genes relevant
to inflammation were significantly upregulated and 40 were downregulated in response to
LPS challenge in mastitis-resistant bMECs, while only one gene was significantly
upregulated and none downregulated in mastitis-susceptible bMECs. This data
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demonstrates a clear difference between the responses of mastitis-resistant and mastitissusceptible bMECs after a 6-hour exposure to LPS. A similar effect has been previously
demonstrated in bMECs from cattle with high and low mastitis susceptibilities based on a
QTL and molecular marked-based selection strategy for milk somatic cell score [157]. In
that study, bMEC lines from cattle with low mastitis susceptibility demonstrated more
rapid and robust differential regulation of genes involved in cell death, neutrophil
chemotaxis, complement system, leukocyte migration, and cell trafficking after challenge
with E. coli or S. aureus than did bMECs from cattle with high mastitis susceptibility.
Changes in the expression of some genes which were ultimately upregulated in both
groups in response to pathogen challenge were not apparent until 24 hours after pathogen
inoculation in bMECs from cattle with high mastitis susceptibility. In contrast, these
genes were upregulated in bMECs from cattle with low mastitis susceptibility by 6 hours
after pathogen inoculation, thereby demonstrating more rapid responses to pathogen
challenge [157]. Differences in gene expression noted at 6 hours in this study may reflect
variation in response times between mastitis-resistant and mastitis-susceptible bMECs,
with bMECs from mastitis-resistant cattle displaying more rapid changes in expression of
genes relevant to inflammation. This study provides further evidence that an ability for
rapid inflammatory responses to mastitis pathogens may be an important mechanism for
mastitis resistance mediated by bMECs.
Three genes, CXCL5, GRO1, and CXCL8, were upregulated in either mastitisresistant bMECs only (GRO1 and CXCL8) or in both mastitis-resistant and mastitissusceptible bMECs (CXCL5) following LPS challenge. Among other functions, these
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three genes are involved in neutrophil chemotaxis and activation [179–181]. During the
acute stages of mastitis, neutrophils surpass macrophages as the most numerous
leukocyte type in the mammary gland, comprising >90% of the total leukocyte
population in milk [42]. Neutrophils act as effector cells of innate immunity via
phagocytosis of bacteria as well as through bactericidal effects of reactive oxygen species
and other secreted factors [30,42,44]. The rapid upregulation of genes such as CXCL5,
GRO1, and CXCL8 is therefore an expected response following LPS challenge, and
demonstrates the ability of primary bMECs to retain pathogen recognition and
inflammatory response capabilities, as reported by others [39,173].
Upregulation of CXCL5 was noted in both mastitis-resistant and mastitissusceptible bMECs following LPS challenge. In addition to its roles as a chemoattractant
and activator of neutrophils, CXCL5 promotes angiogenesis [182] and fibrosis [183], two
processes involved in tissue repair following inflammation. Expression of CXCL5 is
upregulated in E. coli-infected bovine mammary gland tissue [184] and in primary
bMECs exposed to LPS [173], E. coli [185,186], S. aureus [186], or Klebsiella
pneumoniae [186]. These observations, supported by our findings, highlight CXCL5 as
an important chemokine in bovine mastitis. Interestingly, a QTL for clinical mastitis has
been identified in Norwegian Red cattle within 1 Mb of a cluster of genes encoding CXC
chemokines, including CXCL5 [187], providing further evidence that that variation in
this gene could contribute to mastitis resistance.
Two genes involved in neutrophil recruitment, GRO1 and CXCL8, were
upregulated following LPS challenge in mastitis-resistant bMECs only. This suggests that
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bMECs from mastitis-resistant cattle may have an enhanced ability over bMECs from
mastitis-susceptible cows to rapidly recruit neutrophils to the mammary gland following
exposure to mastitis pathogens. In vivo, the intensity and rapidity of neutrophil
recruitment varies between individual cows, and can contribute to the speed of bacterial
clearance and recovery from mastitis [30].
Among the genes downregulated in mastitis-resistant bMECs following LPS
challenge, downregulation of tumor necrosis factor (TNF) is particularly noteworthy.
Tumor necrosis factor is a multifunctional, pro-inflammatory cytokine with well-known
roles in the pathogenesis of mastitis, and is upregulated by mammary gland macrophages
and bMECs during mastitis [188]. Similarly, TNF is upregulated in primary bMECs
following challenge by E. coli or LPS, with most studies reporting increased expression
by 6 hours after challenge and more marked increases after 12-24 hours [39,118,170]. In
this study, TNF expression was not significantly different following a 6-hour LPS
challenge in mastitis-susceptible bMECs, but was significantly different between
unchallenged and LPS-challenged, mastitis-resistant bMECs. As discussed above, the
time required for mastitis-susceptible bMEC to respond to LPS may exceed the 6-hour
time period used in this study, providing a possible explanation for the lack of an
observed change in TNF expression.
More striking is the pattern of TNF expression difference noted among mastitisresistant bMECs. Tumor necrosis factor expression was significantly downregulated,
rather than upregulated, by nearly ten-fold following LPS challenge. Tumor necrosis
factor is known to influence the severity of clinical signs of mastitis [24]. High levels of
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TNF induce both local and systemic effects contributing to the morbidity and mortality in
E. coli mastitis, including promoting the development of endotoxic shock during coliform
mastitis [189]. High milk and plasma TNF concentrations as a result of LPS-induced
mastitis have been noted conjunction with excessive milk concentrations of nitric oxide
and severe systemic clinical signs [190]. Conversely, inhibition of TNF expression during
mastitis appears to have a protective effect on the mammary gland. For example,
decreased severity of histopathologic changes in the mammary gland in a mouse model
of mastitis [191] and the severity of E.coli mastitis-induced local and systemic signs in
cattle [189] were noted in conjunction with administration of treatments that decreased
TNF expression. Given the known contributions of TNF to mastitis severity,
downregulation could be an important mechanism for mastitis resistance. In fact, a paritydependent association was identified between, and polymorphism within, the TNF gene
and clinical mastitis variables in Holstein-Friesian dairy cattle [192], further supporting a
potential role of this gene in mastitis resistance.

Conclusions
Bovine MECs from mastitis-resistant and mastitis-susceptible cattle display
differences in the expression of genes relevant to inflammation in response to LPS
challenge. Upregulation of CXCL5, a gene involved in neutrophil recruitment and
activation, occurs in both groups, while upregulation of two additional genes involved in
neutrophil recruitment was observed in mastitis-resistant but not mastitis-susceptible
bMECs. Additionally, 40 immune genes were downregulated in mastitis-resistant
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bMECs, including TNF, which may be beneficial in minimizing the clinical severity of
mastitis. These results suggest that a possible mechanism for mastitis resistance provided
by bMECs may be an enhanced capacity by mastitis-resistant bMECs as compared with
mastitis-susceptible bMECs to respond rapidly to exposure to mastitis pathogens.
Differences in gene expression were not observed between mastitis-resistant and mastitissusceptible bMECs under unchallenged conditions, indicating that immune responses
rather than constitutive immune gene expression are more important in the contribution
of bMECs to mastitis resistance.
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Table 5: Significant (p < 0.05) inflammatory gene expression fold-changes (2) in LPSchallenged relative to unchallenged bMECs from mastitis-resistant and mastitissusceptible cows. P-values are shown.
Gene Symbol

Gene

Fold-change

P-value

Mastitis-resistant bMECs
Upregulated
CXCL5

Chemokine (C-X-C motif) ligand 5

9.1

0.004001

GRO1

Chemokine (C-X-C motif) ligand 2

5.84

0.001459

CXCL8

Interleukin 8

3.76

0.008736

Downregulated
C5

Complemet component 5

-18.93

0.009573

CCR5

Chemokine (C-C motif) receptor 5

-18.89

0.009591

IL13

Interleukin 13

-18.74

0.012933

PF4

Platelet factor 4

-17.81

0.009447

CCL11

Chemokine (C-C motif) ligand 11

-17.56

0.009998

LOC510185

Interleukin 2 receptor, beta

-17.34

0.010016

CCR2

Chemokine (C-C motif) receptor 2

-17.34

0.010016

CXCL10

Chemokine (C-X-C motif) ligand 10

-17.3

0.010019

CD40LG

CD40 ligand

-16.29

0.010186

CCR1

Chemokine (C-C motif) receptor 1

-16.22

0.010134

IL7

-15.74

0.010203

-15.68

0.010319

CCR4

Interleukin 7
Chemokine (C-X3-C motif) receptor
1
Chemokine (C-C motif) receptor 4

-15.47

0.010258

IL27

Interleukin 27

-15.45

0.010259

IL3

Interleukin 3

-14.8

0.010412

CXCR3

Chemokine (C-X-C motif) receptor 3

-14.68

0.010452

IL16

Interleukin 16

-14.38

0.010472

CCR8

Chemokine (C-C motif) receptor 8
Chemokine (C-X3-C motif) receptor
1
Chemokine (C-X-C motif) ligand 9
Tumor necrosis factor (ligand)
superfamily, member 14
Colony stimulating factor 3
(granulocyte)
Interleukin 17B

-14.35

0.010453

-14.23

0.008799

-13.91

0.010708

-13.51

0.009462

-13.17

0.010952

-13.04

0.010758

Lymphotoxin beta
Tumor necrosis factor receptor
superfamily, member 11b
Chemokine (C-C motif) ligand 4

-12.49

0.011005

-11.28

0.010725

-11.22

0.012553

CXCR1

CX3CR1
CXCL9
TNFSF14
CSF3
IL17B
LTB
TNFRSF11B
CCL4
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IL9R

Interleukin 9 receptor

-10.95

0.009601

OSM

Oncostatin M

-10.34

0.011304

IL2RG

Interleukin 2 receptor, gamma

-10.12

0.011248

TNF

Tumor necrosis factor

-9.96

0.013403

IL4

Interleukin 4

-9.11

0.013379

CXCR5

Chemokine (C-X-C motif) receptor 5

-7.9

0.012634

IL15

Interleukin 15

-6.82

0.003445

LTA

Lymphotoxin alpha

-4.92

0.013147

CXCL12

-4.46

0.04327

-4.16

0.040672

IL10RA

Chemokine (C-X-C motif) ligand 12
Tumor necrosis factor (ligand)
superfamily, member 13b
Interleukin 10 receptor, alpha

-3.71

0.016316

CCL17

Chemokine (C-C motif) ligand 17

-3.61

0.030804

IL6R

Interleukin 6 receptor
Tumor necrosis factor (ligand)
superfamily, member 4

-2.5

0.009601

-2.16

0.024155

8.25

0.001102

TNFSF13B

TNFSF4

Mastitis-susceptible bMECs
Upregulated
CXCL5
Downregulated
None

Chemokine (C-X-C motif) ligand 5
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Table 6: Fold expression differences (2) in unchallenged bMECs from mastitis-resistant
relative to mastitis-susceptible cattle. P-values are shown; none are significant (p < 0.05).
Gene Symbol

Gene

Fold-difference

P-value

Higher expression
CXCR1
Chemokine (C-X-C motif) receptor 1
FASLG
Fas ligand
IL15
Interleukin 15
IL33
Interleukin 33

2.01
40.67
2.4
4.44

0.282959
0.207079
0.283571
0.291716

Lower expression
BMP2
Bone morphogenetic protein 2
CCL2
Chemokine (C-C motif) ligand 2
CCL5
Chemokine (C-C motif) ligand 5
CXCL5
Chemokine (C-X-C motif) ligand 5
CXCL8
Interleukin 8
GRO1
Chemokine (C-X-C motif) ligand 2
HPRT1
Hypoxanthine phosphoribosyltransferase 1
IL10RB
Interleukin 10 receptor, beta
IL1A
Interleukin 1, alpha
IL1R1
Interleukin 1 receptor, type 1
IL1RN
Interleukin 1 receptor antagonist
IL6R
Interleukin 6 receptor
TBP
TATA box binding protein
TNFSF10
Tumor necrosis factor (ligand) superfamily, member 10
TNFSF13
Tumor necrosis factor (ligand) superfamily, member 13
TNFSF4
Tumor necrosis factor (ligand) superfamily, member 4
VEGFA
Vascular endothelial growth factor A

-4.31
-3.84
-4.4
-3.49
-3.06
-4.09
-2
-2.78
-2.36
-2.08
-3.04
-2.23
-2.65
-2.42
-2.5
-2.08
-2.73

0.166194
0.242192
0.277475
0.067625
0.25974
0.112732
0.116871
0.255559
0.269131
0.276355
0.276084
0.276033
0.252476
0.279517
0.2726
0.457644
0.063398
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CHAPTER 4
PRIMARY BOVINE DERMAL FIBROBLASTS DISPLAY SIMILAR INTERLEUKIN
1β EXPRESSION CHANGES TO PRIMARY BOVINE MAMMARY EPITHELIAL
CELLS IN RESPONSE TO LIPOPOLYSACCHARIDE

Abstract
Mastitis is an important disease among dairy cattle worldwide. Primary bovine
mammary epithelial cells (bMECs) provide an in vitro model for studies of the bovine
mammary gland, including investigations of the cellular mechanisms involved in mastitis.
Bovine milk provides a source of viable bMECs and establishment of bMECs from this
source is a non-invasive, repeatable method that is more practical than explant methods.
However, establishment of primary bMECs from bovine milk is challenging due to the
low concentration of bMECs, generally requiring a large volume of milk. Bovine
fibroblasts (bFs) are a second resident cell type involved in immune responses to
intramammary infection, and are readily established and maintained in culture. In order to
systematically investigate the common or differential innate immune responses to
mastitis-causing pathogens between bMECs and bFs, we established primary bMEC and
bF lines from seven lactating Holstein cattle and profiled the inflammatory responses of
bMECs and bFs to lipopolysaccharide (LPS) challenge using the Fluidigm Biomark HD
system. Additionally, we describe a method for establishment of primary bMECs from
bovine milk with reduced milk volume and FBS requirements. Under static
(unchallenged) conditions, bFs demonstrate significantly different expression from
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bMECs of interleukin 1α (IL1A), IL-1 receptor antagonist (IL1RN), C-C motif
chemokine ligand 20 (CCL20), C-X-C motif chemokine ligand 5 (CXCL5), IL-1 receptor
1 (IL1R1), and IL-6. In response to LPS challenge, both bMECs and bFs downregulate
IL-1β (IL1B), and bMECs additionally downregulate CCL20. Therefore, bFs could
potentially be used as a model for bMEC IL1B responses but may not provide a universal
model for bMEC inflammatory gene responses.

Background
Mastitis is the most prevalent production-related disease among dairy cattle and is
associated with substantial economic impacts [193]. Decreased milk yield accounts for
much of the cost associated with mastitis [194] and is a result of temporary or permanent
functional compromise of the mammary gland by direct pathogen effects or
inflammatory-mediated damage [55].
The inflammatory response to mastitis pathogens is due to contributions from
multiple cell types. Bovine mammary epithelial cells (bMECs), lining the teat canal,
ductal system, and alveoli, are extensively involved in innate defenses against invading
pathogens. In addition to providing a physical barrier against bacterial entry into
mammary tissue via tight junctions, these cells have the capacity to initiate components
of the inflammatory response through the production of cytokines, chemokines, and other
secreted factors. Secreted factors with bacteriostatic, bactericidal, and/or modulatory
effects on inflammation include lactoferrin, citrate, xanthine oxidase, arachidonic acid
metabolites, and host defense peptides [30]. Mammary epithelial cells are capable of
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recognizing antigen from invading organisms through expression of pattern recognition
receptors, including Toll-like receptors (TLR) 2 and 4, facilitating generation of
pathogen-specific cytokine/chemokine profiles. Intramammary infection by Escherichia
coli, an important mastitis pathogen, initiates the release of cytokines by bMECs,
including interleukins (ILs), chemokines, and tumor necrosis factor (TNF) [30,195].
Because of the importance of bMECs in mastitis, bMEC immune responses have
been examined in numerous in vitro and in vivo studies. In vitro studies provide a
practical approach whereby immune responses of bMECs can be isolated from other
mammary gland and systemic components within a highly controlled environment.
Primary bMECs retain characteristics of MECs in vivo, including epithelial morphology,
desmosomes, abundant tonofilaments, and formation of acinar structures [177,196], and
gene expression of cytokeratins, casein, and whey proteins [197,198]. Additionally,
primary bMECs are capable of eliciting pathogen-specific inflammatory responses by
differential expression of multiple inflammatory components, including lactoferrin, IL1β, IL-8, TNF-α, serum amyloid A, and β-defensin [38,170]. Furthermore, the effects of
factors such as energy balance in the donor animal on bMEC responses can be studied
[171]. Variation in immune responses of primary bMECs from donor animals with
differing levels of susceptibility to mastitis have been demonstrated. For example,
primary bMECs from animals classified as exhibiting high and low susceptibility to
mastitis based on genotype at a quantitative trait locus for udder health traits on BTA 18
showed differential expression of several key innate immune genes in response to
challenge by two mastitis pathogens [118]. Additionally, a faster and stronger immune
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response was initiated in primary bMECs from less susceptible animals [157]. These and
other studies support the usefulness of primary bMECs in studies to elucidate specific
mechanisms underlying mastitis pathogenesis, including mastitis resistance.
Primary bMECs may be established from explant culture of mammary gland
tissue or from isolation from bovine milk. Explant culture requires postmortem or biopsy
tissue, the acquisition of which requires euthanasia or an invasive procedure. As stated in
its policy on the use of animals in research, the American Veterinary Medical Association
recommends the use of non-animal methods and “refinement of experimental methods to
eliminate animal pain and distress” [199], which can be achieved with the use of in vitro
models attained by minimally-invasive methods. Bovine milk provides a source of viable
bMECs for primary culture and presents a non-invasive, repeatable, and practical
alternative to explant methods. Previously reported methods of bMEC establishment
from milk require collection of a large volume of milk, which may be impractical under
some circumstances. Here, we describe a method by which bMECs can be successfully
established from a reduced volume of milk.
In addition to bMECs, bovine fibroblasts (bFs) are a resident component of the
mammary gland and contribute to inflammatory responses during mastitis [200].
Differences in inflammatory responses of primary bFs between individual animals have
been demonstrated to be reflective of mammary gland immune responses in vivo [201].
Like bMECs, bFs should be considered as potential contributors to mastitis susceptibility.
In vitro models based on primary cell culture are vital in differentiating the
contributions of specific cell types to mastitis under highly controlled conditions. As the
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inflammatory responses of both bMECs and bFs may contribute to mastitis susceptibility,
defining the responses of both to inflammatory stimuli is expected to yield a more
complete picture of the mechanisms of mastitis resistance than would the study of one
cell type alone. Direct comparisons between the responses of these two cell types from
the same individual cattle are needed to better define the mechanisms of mastitis
resistance. In order to compare inflammatory responses, we isolated bMECs and bFs
from seven lactating Holstein dairy cows and examined differences between the two cell
types in the expression of 13 pro-inflammatory genes under unchallenged as well as
lipopolysaccharide (LPS)-challenged conditions.

Methods
Bovine MEC collection, isolation, and establishment
Seven primary bMEC lines were established from bovine milk using methods
modified from those previously reported [39,177]. Milk samples for bMEC isolation
were collected from lactating Holstein cows in the milking parlor prior to attachment of
the milking cluster. Prior to milk collection, teat ends were cleaned and disinfected with a
7.5% povidone-iodine solution applied with a spray bottle. Disinfectant was allowed
approximately ten seconds contact time before being removed using a clean paper towel.
Four hundred ml of milk was then hand-stripped from one or more mammary gland
quarters into sterile, 1 liter-capacity plastic bottles containing an equal volume of
collection media. Collection media consisted of Hank’s Balanced Salt Solution (SigmaAldrich, St. Louis, MO) supplemented with penicillin (60 μg/ml), streptomycin (200
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μg/ml), gentamycin (120 μg/ml), and nystatin (50 mg/L). Samples were kept on ice
within an insulated container for transport to the laboratory and short-term storage (up to
four hours) prior to cell isolation.
In all subsequent steps where sample containers were open, samples were handled
within a cell culture hood to maintain asepsis. Milk samples were divided into two 500ml capacity conical centrifuge bottles and centrifuged for ten minutes at 3000 rpm at
room temperature. The supernatant was discarded, and the cell pellets were resuspended
in 12 ml of fresh collection media and transferred into a 50 ml sterile conical tube.
Resuspended cell pellets from the same individual animal were combined into the same
50 ml tube. Samples were centrifuged for ten minutes at 3000 rpm at room temperature.
The supernatant was discarded, and the remaining cell pellet resuspended in 24 ml of
fresh collection media and transferred to a new 50 ml conical tube through a 100 µm cell
strainer. Samples were centrifuged again at 3000 rpm for ten minutes at room
temperature, and the supernatant discarded. The cell pellet was resuspended in 5 ml of
growth media with 10% FBS, seeded into a T-25 culture flask, and incubated at 38.5°C
with 5% CO2. Growth media consisted of HuMEC Ready Medium (Life Technologies,
Grand Island, NY) supplemented with penicillin (60 μg/ml), streptomycin (200 μg/ml),
gentamycin (120 μg/ml), and nystatin (50 μg/ml). After 12-18 hours, media was
exchanged for growth media without FBS. Media was changed every 2-3 days. After
large, coalescing colonies formed or the culture had reached confluence, cells were
passaged using trypsin 0.05%/EDTA 0.02% (Sigma-Aldrich, St. Louis, MO). Cells were
maintained to the second, at which point LPS challenge was carried out.
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Bovine fibroblast collection, isolation, and establishment
Bovine fibroblast primary cultures were established as previously described [202],
with some modifications, from dermal ear notch samples from the cows for which bMEC
lines were established. Ear notches were rinsed in a 7.5% povidone-iodine solution
followed by 70% ethanol, and transferred into collection media as described above for
transport to the laboratory on ice. Under a cell culture hood, ear notches were minced to 2
mm3 pieces, with exclusion of the epidermis and hair. Tissue pieces were rinsed twice
with collection media and transferred to cell culture wells containing 0.25% trypsin. After
a one-hour incubation at 37˚C with 5% CO2, trypsin was exchanged for growth media as
described above with 10% FBS. Media was exchanged every 2-3 days thereafter. Once
adherent monolayer cells morphologically consistent with fibroblasts had formed around
explant tissue pieces, tissue was removed. Cells were passaged when confluence was
reached as described for bMECs. Cells were maintained to the second passage, at which
point LPS challenge was carried out.

Cell lineage verification
Verification of epithelial lineage of representative bMECs was achieved using
observation of cell morphology and cytokeratin 8 (KER8) expression as determined by
polymerase chain reaction (PCR). Observations of cell morphology were made at P0 and
all subsequent passages using phase-contrast microscopy. Primers for KER8 were
designed using Primer3Plus (http://primer3plus.com/cgi-bin/dev/primer3plus.cgi) and
based on NCBI reference sequence NM_001033610.1 and were as follows: forward
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primer AATCAAGTATGAGGAGCTGC; reverse primer
CATCCTTAACAGCCATCTCA. Polymerase chain reaction conditions consisted of
initial denaturation at 98˚C for 30 seconds followed by 32 cycles of 98˚C for 10 seconds,
57 ˚C for 15 seconds, and 72˚C for 30 seconds. Gel electrophoresis was used to confirm
the presence of PCR product. Sequencing of PCR product to confirm KER8 amplification
was carried out by the Center for Integrated Biotechnology, Utah State University
(Logan, UT). Uniformity of cytokeratin expression was also confirmed by
immunocytochemistry using a rabbit anti-cytokeratin, wide spectrum screening primary
antibody (Z0622; Agilent Technologies, Santa Clara, CA), carried out by the Utah
Veterinary Diagnostic Laboratory (Logan, UT).

LPS challenge and RNA isolation
Bovine MECs and bFs were exposed to LPS from Escherichia coli 0111:B4
(Sigma-Aldrich, St. Louis, MO) to mimic exposure to a mastitis-causing pathogen.
Lipopolysaccharide challenge methods were similar to those described previously [173].
Briefly, bMECs and bFs were split after the second passage into two T-25 culture flasks.
Once 50-100% confluence was reached, media was exchanged for growth media with or
without 50 µg/ml LPS. Cells were incubated at culture conditions for 6 hours, after which
media was removed.
Following LPS challenge, bMECs and bFs were lysed and total RNA was isolated
and purified using the Purelink RNA Mini Kit (Life Technologies, Carlsbad, CA)
according to the manufacturer’s instructions. Quality of the RNA (RNA integrity number
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> 8.0) was verified using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA). Complementary DNA was generated using the SuperScript® VILOTM cDNA
Synthesis Kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions,
with reverse transcription PCR conditions as follows: primer annealing at 25˚C for 10
minutes, reverse transcription at 42˚C for 1 hour, and enzyme inactivation at 85˚C for 5
minutes.

Quantitative PCR for gene expression
Relative expression of 13 pro-inflammatory genes was assessed via quantitative
PCR (qPCR). Genes were selected based on known roles in inflammation and/or bovine
mastitis and included Toll-like receptor 4 (TLR4), interleukin-6 (IL6), IL33, IL1α, IL1β,
IL2 receptor subunit gamma (IL2RG), IL1 receptor antagonist (IL1RN), IL1 receptor
type 1 (IL1R1), C-X-C motif chemokine ligand 5 (CXCL5), interleukin 8 (CXCL8), C-C
motif chemokine receptor 2 (CCR2), C-C motif chemokine ligand 20 (CCL20), and
chemokine (C-X-C motif) ligand 1 (GRO1). Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and ubiquitously expressed transcript protein (UXT) were used as reference
genes. Primers were designed using Primer3Plus (http://primer3plus.com/cgibin/dev/primer3plus.cgi) and are shown in Table 7. Efficiency of all primers was between
80-110%.
Quantitative PCR was performed by the Utah State University Center for
Integrated Technology (Logan, UT) using BioMark technology (Fluidigm) and EvaGreen
(Bio-Rad) detection chemistry. The ΔΔCt normalization method was used for relative
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quantification as implemented by Fluidigm Real-Time PCR Analysis software
(Fluidigm). Results were analyzed in a mixed model approach implemented in SAS®
statistical software, Version 9.4 [203], using the “proc mixed” command, with a
significance level set at p < 0.05. Comparisons in expression of the 13 genes were made
between bMECs and bFs under unchallenged conditions. Additionally, expression of
these genes was compared between unchallenged and LPS-challenged bMECs and
between unchallenged and LPS-challenged bFs.

Results
Improved bMEC isolation methods
Methods described for bMEC establishment include explant culture from
mammary gland biopsies or postmortem tissue and isolation from bovine milk.
Establishment of primary bMECs from postmortem tissue carries the disadvantage that
further cultures at a later time cannot be obtained from the same cow. Additionally,
slaughter of cattle solely to obtain such tissue may be economically impractical as well as
ethically questionable. Mammary gland biopsies can overcome these problems, but are
time-consuming and may not be practical under some circumstances, particularly if
repeated establishment of cell lines from the same animals is required. With both these
methods, other cell types such as bFs are isolated along with bMECs and steps must be
taken to remove these contaminating cell types [170,176]. Establishment of primary
bMECs from bovine milk is a non-invasive method that minimizes contamination of
bMEC lines by bFs and other cell types relative to explant-based methods [177,204].
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We successfully established bMEC primary cultures from bovine milk from a
reduced volume of milk (400 ml) as compared with previously-reported methods.
Moreover, use of hand-milking for milk collection, use of collection media supplemented
by antimicrobials, and centrifugation speed of 3000 rpm during isolation steps were
important factors. Additionally, use of FBS in bMEC culture media can be minimized, as
FBS was eliminated from the culture media from the first media change onward.
All established bMEC lines demonstrated cell and colony morphology uniformly
consistent with their respective expected cell types. Among bMEC lines, rare to moderate
numbers of individual, adherent cells with polygonal morphology, oval nuclei, and
elongated cytoplasmic processes were present by 12 hours after seeding. By four days
after seeding, colonies of 2-5 cells were observed, demonstrating the cobblestone
arrangement and polygonal individual cell morphology consistent with MECs grown on
monolayer [205–207]. Cultures had formed large, coalescing colonies by 21-28 days after
seeding and were initially passaged at this time. Cellular senescence was identified by
prominent flattening, enlargement, and nuclear vacuolation of cells in addition to a
cessation of cell division. Senescence among a majority of cells, with no further growth
of colonies, was observed in occasional cell lines at initial passage (P0) and P1 and these
cultures were excluded from the LPS challenge study. However, most cell lines did not
exhibit senescence among a majority of cells by confluence at P2. All bMEC lines
expressed KER8. Immunocytochemistry demonstrated cytokeratin expression in the
majority of cells in a representative bMEC line.
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Primary bFs formed small colonies of spindle-shaped cells bordering explant
tissue pieces and reached confluence within 7-10 days. All bF lines demonstrated
uniform sheets and individual cell morphology consistent with primary fibroblasts on
monolayer.
Our results demonstrate that primary bMEC lines can be established from 400 ml
of bovine milk. The use of a small volume of milk allows for a reduction in the time
required for sample collection, improving the utility of this method.

Constitutive expression of inflammatory genes differs between bMECs and bFs
To investigate differences in constitutive expression of pro-inflammatory genes
between bFs and bMECs, we evaluated the expression of 13 pro-inflammatory genes by
qRT-PCR in unchallenged cell lines. Four genes, IL6, ILR1, CXCL5, and CCL20, were
significantly (p < 0.05) more highly expressed in bMECs than bFs under unchallenged
conditions, while two genes, IL1RN and IL1A, were more highly expressed in bFs (Table
8). Results show that constitutive expression of a number of pro-inflammatory genes
varies between bFs and bMECs. This finding highlights the importance of examining the
two cell types separately when conclusions are drawn regarding possible influences of
mammary gland constitutive gene expression in mastitis.
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Expression of pro-inflammatory genes between bMECs and bFs upon LPS challenge
Changes in the expression of 13 pro-inflammatory genes between the two cell
types as a result of LPS challenge were compared.
Lipopolysaccharide challenge resulted in differential expression of two proinflammatory genes among bMECs and one pro-inflammatory gene among bFs. Among
bMECs, both IL1B and CCL20 were significantly downregulated. Among bFs, IL1B was
significantly downregulated (Table 9). The expression of the remaining 11 genes
examined was not significantly affected by LPS challenge in either cell type. These
findings demonstrate that in response to LPS, both cell types respond similarly with
regard to changes in expression of IL1B, an important cytokine in bovine mastitis. The
pattern of expression of CCL20, however, differs between the two cell types in response
to LPS. Therefore, bFs could potentially be used as a model for bMEC IL1B responses
but may not provide a good universal model for bMEC inflammatory gene responses.

Discussion
Primary bMEC cultures can be established from a small volume of bovine milk with
minimal use of FBS
Our results reinforce that bovine milk provides a source of viable bMECs that can
be collected non-invasively and repeatedly. Challenges encountered in bMEC primary
culture from bovine milk include recovery of an adequate number of viable bMECs and
avoidance of culture contamination by bacterial and fungal organisms. In our experience,
obtaining milk through hand-milking, use of collection media and antimicrobials, and a

93
centrifugation speed of 3000 rpm during isolation steps contributed to the success of
establishing bMEC primary cultures from a 400 ml volume of milk.
The concentration of viable bMECs detected within milk from dairy cattle tends
to be low [204,208]. As such, previously-reported methods for bMEC isolation from milk
require relatively large volumes of milk, at 950 ml or greater [39,171,177], which may be
impractical in some settings. For example, as we experienced, sampling of cows on a
commercial farm within the milking parlor may unduly disrupt the milking schedule due
to the time required to collect a large volume of milk. Reducing the volume of milk
needed allows disruption to be minimized.
In previously reported methods of bMEC establishment from milk [39,171,177],
the technique of milk collection is unspecified. In our experience, collection of milk by
mechanical milking equipment resulted in a lower rate of successful bMEC
establishment, as well as a higher number of cultures discarded as a result of bacterial
contamination, than did manual collection by hand-milking. We speculate that manual
collection may result in less cellular damage from shearing stress to bMECs, and
therefore a higher success rate, than does milking by mechanical means. In the setting of
a commercial dairy farm, as was used in our study, hand milking additionally lends a
higher degree of control over maintaining asepsis, thereby reducing bacterial and fungal
contamination. We observed a lower frequency of bacterial contamination of bMEC
cultures obtained through manual sampling than those obtained through mechanical
milking, in agreement with a previous study [209].
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During the initial centrifugation step in bMEC isolation, cells are separated from
the majority of the liquid and fat components of the milk. A variable amount of fat
separates from the liquid component and forms a layer on the surface of the milk during
centrifugation, while cells, debris, and some fat form a pellet beneath the liquid layer.
However, in agreement with a previous study [210], we suspect that some cells may
become trapped in the upper fat layer of the milk during centrifugation. Dilution of the
sample with collection media may help to minimize cell trapping by reducing the
viscosity of the milk and the concentration of lipids, allowing cells to more easily pellet
during centrifugation.
We experimented with low (2000 rpm) to high (4000 rpm) centrifugation speeds
during bMEC isolation attempts, and found that centrifugation at 3000 rpm was optimal
for establishment of bMEC lines. We believe that low-speed centrifugation may cause
less damage to cells, preserving viability, but may leave many cells remaining in
suspension. High-speed centrifugation may result in a larger number of cells recovered
from suspension, but may cause cellular damage and decreased viability (Gertrude C.
Beuhring, personal communication).
Antimicrobials in collection media and growth media were used to prevent
bacterial and fungal contamination of bMEC and bF cultures. Prior to the use of
antimicrobial-supplemented collection media, we observed a higher rate of contamination
of bMEC and bF cultures at initial establishment or early passages. Although milk
samples for bMEC establishment were collected with asepsis in mind, some level of
contamination by environmental debris nevertheless occurred, evident as grossly or
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microscopically visible acellular debris embedded within the cell pellet following
centrifugation. We expect that the use of antimicrobials helped to control bacterial and
fungal proliferation in milk and ear notch samples prior to seeding of isolated cell pellets
or explant tissue, respectively, into antimicrobial-supplemented growth media. Overall,
evidence of bacterial contamination was uncommon when milk was collected manually.
However, fungal contamination of cultures at early passages was common in both bMEC
and bF lines when no collection media was used or when amphotericin B was used as an
antifungal. As a result, we substituted nystatin for amphotericin B in both collection and
growth media. Concurrently, the source of the iodine disinfectant used to clean teats prior
to sampling was switched from the on-farm pre-dip solution to a solution prepared
aseptically in the laboratory. The use of this iodine disinfectant was also added to the bF
isolation protocol, wherein ear notches were rinsed with the iodine solution prior to
ethanol rinsing. The implementation of these changes successfully prevented fungal
contamination in bMEC and most bF lines.
In previously reported methods of bMEC isolation and culture from milk, FBS or
fetal calf serum (FCS) is used in the culture media at concentrations of 5-10% in growth
media in order to facilitate cell-substrate attachment and achieve sustained growth of
bMECs [38,39,170,177]. However, the use of serum in cell culture media has a number
of disadvantages. The components of serum, as well as their concentrations, are
incompletely defined, and may exhibit large lot-to-lot variation. Serum is additionally a
potential source of hemoglobin, endotoxin, and microbial contaminants, all of which have
the potential to influence cellular responses and experimental results [211]. Serum can
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inhibit the growth of some epithelial cell types, including human mammary epithelial
cells [206,212]; a similar effect on bMECs is possible. Furthermore, the presence of
serum in media may influence inflammatory cytokine secretion or bioactivity by bMECs
[213]. These considerations, in addition to the expense and ethical concerns regarding the
collection of serum from bovine fetuses, justify development of cell culture methods that
minimize or eliminate the use of serum in cell culture [211,214]. Human MECs have
been cultured successfully in serum-free media, and may in fact be more easily cultured
using alternatives to FBS [206]. In our studies, we found that FBS is required for initial
attachment of bMECs, as reported previously [177]. However, using a specialized serumfree media developed for human MEC culture, we were able to eliminate FBS from the
growth media from the first media change onward.
Isolation of bMECs from bovine milk has some disadvantages, such as a low
number of cells relative to what can be achieved through explant culture [177]. However,
in studies that do not require a large number of cells, isolation from milk provides a
number of advantages over explant culture. The modifications described here to
previously-reported milk isolation methods improve the versatility of bMEC isolation
from milk by reducing the volume of milk needed and minimizing the requirement for
serum.

The use of bFs in mastitis studies
Fibroblasts are a component of the bovine mammary gland and respond to
intramammary infection by secretion of cytokines such as TNF-α and IL-6 [215]. In vitro,
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mammary gland-derived bFs from donor animals with and without intramammary
infection display differential expression of genes involved in cell junction and adhesion,
immune response, and biosynthesis/metabolism cellular pathways, and additionally affect
proliferation and secretion of TNF-α and IL-8 by co-cultured bMEC [215]. Dermal bFs
exposed in vitro to LPS display increased expression of IL-8, IL-6, and some matrix
metalloproteinases [201,216,217].
Similar to bMECs, individual animal variation has been observed in immune
responses of primary bFs. Variability in IL-6, IL-8, and TLR-4 expression between
dermal bF lines from different animals was noted upon in vitro exposure of these cells to
LPS or IL-1β [201,216,218]. Intriguingly, responses of dermal bFs to LPS in vitro were
predictive of the rate of mastitis resolution and return to mammary gland productive
capacity upon intramammary infusion of Escherichia coli in lactating Holstein cows
[201]. These findings indicate that primary bFs, like bMECs, have the potential to
provide a suitable model for certain mastitis studies. We demonstrate that bFs and
bMECs respond similarly to LPS challenge in their expression of IL1B, but demonstrate
differences in CCL20 expression.

IL1B is downregulated by both bMECs and bFs following LPS challenge
The role of IL1B in bovine mastitis is well recognized. Interleukin 1β has been
detected in both healthy and infected bovine mammary glands [219] and is produced by
monocytes/macrophages, bMECs, and possibly mammary gland endothelial cells
[213,220]. Functions during mastitis include neutrophil chemotaxis and adhesion
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molecule expression by endothelial cells. The relative importance of IL1B responses in
mastitis varies by pathogen [220], but increased expression in the mammary gland is
observed in the acute stages of mastitis caused by several important pathogens, including
Streptococcus uberis [221], Escherichia coli [195,222], and Staphylococcus aureus
[222]. Measurement of serum IL1B and calculation of the serum IL1RN:IL1B ratio has
been suggested as a predictive assay for mastitis severity in cattle [219]. Our finding that
IL1B was downregulated following LPS exposure is in contrast to many studies that
demonstrate upregulation of IL1B in response to inflammatory stimuli, although
downregulation of IL1B in bovine mammary tissue with mastitis has been reported [223].
The finding that bFs show similar IL1B responses to LPS to bMECs suggests that
bFs could be used in place of bMECs in understanding some aspects of the immune
responses of mastitis. Changes in IL1B expression by bFs could potentially be used as a
tool for predicting bMEC immune responsiveness to various conditions. For example,
bFs could be used in the initial investigation of compounds theorized to dampen bMEC
responses and thereby reduce inflammatory-mediated damage to the mammary gland
during mastitis. The responsiveness of bFs in place of bMECs to LPS in the presence of
these compounds could be evaluated. Because bFs grow more readily and rapidly in
culture than bMECs, bF-based models have the potential to improve the efficiency of
such initial investigations, the findings of which could be used as guidance for the
direction of more targeted investigations using bMECs or in vivo models.
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CCL20 is downregulated in bMECs but not in bFs following LPS challenge
CCL20 is a pro-inflammatory chemokine involved in recruitment of leukocytes
[224]. Upregulation of CCL20 by the mammary gland and primary bMECs in response to
mastitis pathogens has been demonstrated [225].
Although IL1B responses of bFs and bMECs were similar, the two cell types
displayed distinct CCL20 responses following LPS challenge, with differential
expression noted only in bMECs. This finding demonstrates that bFs cannot be assumed
to universally mimic bMECs and as such cannot be used in place of bMECs for some
mastitis studies.

Conclusions
Constitutive expression of IL6, ILR1, CXCL5, CCL20, IL1RN, and IL1A differ
between primary bFs and bMECs under unchallenged conditions, indicating a need to
examine each cell type separately in studies of constitutive mammary gland gene
expression. Following LPS challenge, both cell types respond by downregulating IL1B,
while CCL20 is downregulated in bMECs only. Bovine fibroblasts may therefore be of
use as a model for bMEC IL1B expression responses during mastitis but may not be
appropriate when the expression of some other inflammatory genes are examined.
Primary bMEC cultures can be established from 400 ml of bovine milk and with reduced
FBS use by the methods described here.
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Table 7: Primers used for qPCR.
Symbol

Gene

Primer

Sequence

NCBI sequence

CCL20

C-C motif chemokine
ligand 20

F

TTGATGTCAGTGCTATTGCT

NM_174263.2

R

ACCCACTTCTTCTTTGGATC

F

GTGCCCCTTATTTTCCACTA

R

GAGCCCAGAAGAGAAAGTAG

F

TGTGTTTAACCACCACACC

R

TTGTTCTTTCCACTGTCCA

CCR2

CXCL5

C-C motif chemokine
receptor 2

C-X-C motif chemokine
ligand 5

NM_001194959.1

NM_174300.2

CXCL8

Interleukin 8

F
R

AAACACATTCCACACCTTTC
TCTTCACAAATACCTGCACA

NM_173925.2

GRO1

chemokine (C-X-C
motif) ligand 1

F

ATTCACCTCAAGAACATCCA

NM_175700.1

R

GCACTAGCCTTGTTTAGCAT

IL1A

Interleukin 1 alpha

F
R

GAAGAGGATTCTCAGCTTCC
GATGGGCAACTGATTTGAAG

NM_174092.1

IL1B

Interleukin 1 beta

F
R

CTTGGGTATCAAGGACAAGA
TGAGAAGTGCTGATGTACCA

NM_174093.1

Interleukin 1 receptor
type 1

F

GAGACAATGGAAGTGGTCTT

NM_001206735.1

R

GAAATATTAAGCCGTGCGAG

F

CACTGACTTGAACCAGAACA

R

GCTGGAAGTAGAACTTGGTG

F

AATTCCAGCTAGAACTGAGC

R

TTCCGCAAAGTGGGTTATAA

IL1R1

IL1RN

IL2RG

Interleukin 1 receptor
antagonist

Interleukin 2 receptor
subunit gamma

AB005148.1

NM_174359.1

IL33

Interleukin 33

F
R

CAACCAAGAGAAAGACAAGG
CTCCACAGAGTGCTCCTTAC

NM_001075297.1

IL6

Interleukin 6

F
R

ACTGCTGGTCTTCTGGAGTA
CTTTACCCACTCGTTTGAAG

NM_173923.2

Toll-like receptor 4

F
R

GCATGGAGCTGAATCTCTAC
ATAGGGTTTCCCGTCAGTAT

NM_174198.6

TLR4
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Table 8: Genes differentially expressed between bFs and bMECs under unchallenged
conditions.
Symbol

Gene

P-value

SE

More highly expressed in bFs
IL1A

Interleukin 1 alpha

0.0003

1.1784

IL1RN

Interleukin 1 receptor antagonist

<0.0001

1.1848

More highly expressed in bMECs
CCL20

C-C motif chemokine ligand 20

0.0003

1.36

CXCL5

C-X-C motif chemokine ligand 5

0.0415

0.8957

IL1R1

Interleukin 1 receptor type 1

0.0071

1.4813

IL6

Interleukin 6

0.0026

2.1505

SE: Standard Error

Table 9: Genes downregulated following LPS challenge in bFs and bMECs.
Symbol

Gene

P-value

SE

0.0322

1.2603

Downregulated in bFs
IL1B

Interleukin 1 beta

Downregulated in bMECs
IL1B

Interleukin 1 beta

0.0009

1.2603

CCL20

C-C motif chemokine ligand 20

<0.0001

1.36
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CHAPTER 5
EXOGENOUS PHOSPHOLIPASE A2 AFFECTS EXPRESSION OF INTERLEUKIN-8
AND CHEMOKINE (C-X-C MOTIF) LIGAND 1 BY PRIMARY BOVINE
MAMMARY EPITHELIAL CELLS IN RESPONSE TO LIPOPOLYSACCHARIDE

Abstract
Bovine mastitis causes substantial economic losses to the dairy industry.
Phospholipase A2 (PLA2) is an endogenous enzyme involved in phospholipid
metabolism in all mammalian tissues and has both pro-inflammatory and antiinflammatory functions as well as bactericidal characteristics. Modulation of PLA2 levels
locally within tissue has been proposed as a therapeutic approach to various diseases, and
evidence exists for an anti-inflammatory effect when administered as an intramammary
treatment during murine mastitis. Little is known about the effects of exogenous PLA2 on
the bovine mammary gland and its effects on bovine mastitis. We used an in vitro model
to investigate the effects of exogenous PLA2 on primary bovine mammary epithelial cells
(bMECs). We established bMEC lines from 12 lactating Holstein dairy cows and
compared the expression of 13 pro-inflammatory genes under unchallenged and
lipopolysaccharide (LPS)-challenged conditions with and without concurrent treatment
with bovine pancreatic PLA2G1B. No differences in the expression of these genes were
noted between PLA2-treated and untreated bMECs under unchallenged conditions.
However, following LPS challenge, untreated bMECs exhibited significant (p < 0.05)
downregulation of interleukin-8 (IL8), interleukin-1β (IL1B), C-C motif chemokine
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ligand 20 (CCL20), and chemokine (C-X-C motif) ligand 1 (GRO1). In contrast, PLA2treated bMECs exhibited significant downregulation of IL1B and CCL20 only, indicating
that exogenous PLA2 affects the expression of some pro-inflammatory factors in
immune-stimulated bMECs. Further studies are required to determine whether PLA2
affects the expression of other inflammatory genes by bMECs or other mammary gland
cell types, or if a dose-dependent effect exists that was not apparent in this study.

Background
Bovine mastitis has a major impact on the dairy industry due to the substantial
impacts of decreased milk yield, altered milk production, and the costs of diagnostic,
therapeutic, and preventative measures [3,193]. Currently, the majority of dairy cattle
with mastitis are treated with antibiotics, despite evidence indicating that bacteriological
cure rates may not be improved with antibiotic treatment over spontaneous cure rates
[226,227].
Changes in the production capacity of the mammary gland as well as alterations in
milk composition are a result of damage to bovine mammary epithelial cells (bMECs),
the milk-producing compartment. Damage can result from direct effects of mastitis
pathogens on bMECs [228,229]. A substantial portion of damage, however, is a
consequence of the host immune response itself, wherein host defense mechanisms such
as neutrophil degranulation cause bystander-effect cellular injury [47]. Minimizing the
damaging effects of host inflammatory responses should be considered an important
factor in the management of inflammatory diseases such as mastitis. With the use of
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antibiotics alone in cases of bovine mastitis, minimizing inflammation-induced host
tissue damage relies solely on elimination of the infecting organism. Alternative
therapeutic approaches to bovine mastitis that include strategies to minimize host-induced
damage to mammary gland tissue are needed.
One proposed therapeutic approach in the treatment of a number of inflammatory
diseases in various species involves modulation of phospholipase A2 [230]. The
phospholipase A2 superfamily of enzymes are involved in several cellular processes,
including influencing inflammatory processes, predominantly via generation of lipid
mediators. Inhibition of PLA2 activity has therefore been proposed in the treatment of
inflammatory diseases [231]. However, because of the involvement of PLA2 in other
cellular processes such as normal phospholipid metabolism, universal PLA2 inhibition
has potentially detrimental effects, including impairment of cell viability [230].
Therefore, selective modulation of specific PLA2 subtypes, such as secreted PLA2
(sPLA2), may be a more optimal approach [230].
Pro-inflammatory actions of sPLA2 are mediated through intrinsic enzymatic and
bactericidal activity as well as via interaction with the PLA2 receptor expressed on
various mammalian cell types [232,233]. Secreted PLA2 enzymatic activity results in cell
membrane and extracellular phospholipid hydrolysis and the consequent release of
arachidonic acid, which is subsequently converted into eicosanoids to potentiate
inflammation [232,234]. Binding of sPLA2 to transmembrane and soluble forms of the
PLA2 receptor (PLA2R1) evokes additional cell type-specific biological responses,
including initiating receptor-mediated activation of eicosanoid formation independent of
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sPLA2 enzymatic activity [232]. For some sPLA2 subtypes, such as sPLA2-1B, this
receptor-mediated activity is particularly important, as intrinsic hydrolyzing activity
toward intact cell membranes of sPLA2-1B is relatively weak [235]. Additional receptormediated pro-inflammatory effects include influences on plasma pro-inflammatory
cytokine levels during endotoxic shock [232]. Evidence exists for sPLA2 subtypespecific effects upon receptor binding [232]. Interestingly, in addition to potentiating
PLA2 function, PLA2R1-sPLA2 binding also has negative regulatory effects on PLA2
activity. The intrinsic enzymatic activity of sPLA2 is abolished upon receptor binding
[232], and receptor-mediated endocytosis of sPLA2 facilitates clearance of these
enzymes [235]. Binding of sPLA2 to a circulating, soluble form of PLA2 receptor
upregulated during endotoxic shock additionally blocks the biological functions of some
sPLA2 subtypes [235].
Little information is available on the role of PLA2 in the pathogenesis of bovine
mastitis. It is unknown whether endogenous PLA2 activity in the bovine mammary gland
changes as a result of mastitis [236]. Effects of PLA2 noted in other species and tissues
may be extrapolated to the bovine mammary gland only tentatively, as variation in PLA2receptor-binding activity is noted among different mammalian species. For example,
PLA2 receptor binding affinity of sPLA2 subtype sPLA2-1B is high in rodents but low in
humans, and binding of sPLA2-IIA to the PLA2 receptor does not occur in humans [235].
Although PLA2 activity contributes to inflammation-induced damage in some diseases,
as discussed above, there is some evidence for an anti-inflammatory effect of sPLA2
during mastitis. Intramammary administration of bovine PLA2G1B in mice with
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experimental, LPS-induced mastitis reduced inflammation despite displaying no
bactericidal activity [233]. Additionally, the effects of murine PLA2G2D are known to
include the production of anti-inflammatory lipid mediators [237]. Information on the
effects of PLA2 on inflammation in bovine mammary tissue is lacking. Whether PLA2 in
the bovine mammary gland during mastitis has beneficial or detrimental effects has yet to
be described.
Investigation of the effects of PLA2 on bovine mammary gland tissue will indicate
whether further studies of PLA2 or PLA2 inhibitors as potential therapeutic agents are
warranted. The objective of this study was to examine the effects of exogenously
administered PLA2 on inflammatory responses of primary bMECs. To achieve this, we
established primary bMEC lines from 12 lactating Holstein cows and compared the
expression of 13 pro-inflammatory genes in PLA2-treated and untreated cell lines at
unchallenged as well as LPS-challenged conditions.

Methods
Bovine MEC collection, isolation, and establishment
Milk-derived primary bMEC lines were established from adult lactating Holstein
dairy cows. Four hundred milliliters of hand-stripped milk were aseptically collected into
an equal volume of collection media consisting of Hank’s Balanced Salt Solution (Sigma)
supplemented with penicillin (60 μg/ml), streptomycin (200 μg/ml), gentamycin (120
μg/ml), and nystatin (50 mg/L).
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Bovine MEC isolation was carried out as previously reported [39,177] with some
modifications. Briefly, milk samples were subjected to a series of wash and
centrifugation steps (3000 rpm for 10 minutes each) followed by passage of the
resuspended cell pellet through a 100 µm pore size cell strainer to separate cell pellets
from debris and other milk components. Following a final centrifugation step, the cell
pellet was resuspended in 5 ml of growth media consisting of HuMEC Ready Medium
(Life Technologies, Grand Island, NY) supplemented with penicillin (60 μg/ml),
streptomycin (200 μg/ml), gentamycin (120 μg/ml), nystatin (50 μg/ml), and 10% fetal
bovine serum, and seeded into a T-25 culture flask. Cells were incubated at 38.5°C with
5% CO2. After 12-18 hours, media was exchanged for FBS-free growth media. Media
was changed every 2-3 days thereafter.
Cells were passaged when confluency was reached using trypsin 0.05%/EDTA
0.02% (Sigma-Aldrich, St. Louis, MO). Cells were maintained to the third passage, at
which point LPS challenge was carried out.

Cell lineage verification
Verification of epithelial and mesenchymal lineage of bMEC was achieved using
observation of cell morphology and expression of keratin 8 (KER8). Observations of cell
morphology were made at P0 and subsequent passages using phase-contrast microscopy.
Colonies that demonstrated a cobblestone pattern comprised of polygonal cells with
round to oval nuclei typical of epithelial cells were considered likely to be of bMEC
origin. Expression of KER 8, a product of both basal and luminal MECs [178], was
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determined via polymerase chain reaction (PCR). Primers were designed using
Primer3Plus (http://primer3plus.com/cgi-bin/dev/primer3plus.cgi) based on NCBI
reference sequence NM_001033610.1 and were as follows: forward primer
AATCAAGTATGAGGAGCTGC; reverse primer CATCCTTAACAGCCATCTCA.
Polymerase chain reactions were: initial denaturation at 98˚C for 30 seconds followed by
32 cycles of 98˚C for 10 seconds, 57 ˚C for 15 seconds, and 72˚C for 30 seconds. Gel
electrophoresis was used to confirm the presence of PCR product. Sequencing of PCR
product to confirm KER8 amplification was carried out by the Center for Integrated
Biotechnology, Utah State University (Logan, UT).

PLA2 treatment, LPS challenge, and RNA isolation
Each cell line was split into four treatment groups at the second to third passage:
unchallenged, LPS-challenged, unchallenged with PLA2 treatment, and LPS-challenged
with PLA2 treatment. Third-passage bMEC were exposed to LPS from Escherichia coli
to mimic exposure to a mastitis-causing pathogen. Lipopolysaccharide challenge methods
were similar to those described previously [173], with some modifications. Briefly, once
50-100% confluency was reached, media was exchanged for growth media with or
without 50 µg/ml LPS from Escherichia coli (Sigma) and/or 50 µg/ml PLA2G1B from
bovine pancreas (product P8913, Sigma-Aldrich, St. Louis, MO). Cells were incubated at
culture conditions for 6 hours, after which media was removed. Cells were immediately
lysed, and total RNA was isolated and purified using the Purelink RNA isolation kit (Life
Technologies) according to the manufacturer’s instructions. Quality of RNA was
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determined using the BioAnalyzer (Agilent Technologies, Santa Clara, CA).
Complimentary DNA was generated using the SuperScript® VILOTM cDNA Synthesis
Kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions, with RTPCR conditions as follows: primer annealing at 25˚C for 10 minutes, reverse transcription
at 42˚C for 1 hour, and enzyme inactivation at 85˚C for 5 minutes.

Quantitative PCR for gene expression
Relative expression of 13 genes related to inflammation were assessed via
quantitative PCR (qPCR). Genes were selected based on known roles in inflammation
and/or bovine mastitis and included Toll-like receptor 4 (TLR4), Interleukin-6 (IL6),
IL33, IL8, IL1α, IL1β, IL2 receptor subunit gamma (IL2RG), IL1 receptor antagonist
(IL1RN), IL1 receptor type 1 (IL1R1), C-X-C motif chemokine ligand 5 (CXCL5),
CXCL8, C-C motif chemokine receptor 2 (CCR2), C-C motif chemokine ligand 20
(CCL20), and chemokine (C-X-C motif) ligand 1 (GRO1). GAPDH was used as a
reference gene. Primers were designed using Primer3Plus (http://primer3plus.com/cgibin/dev/primer3plus.cgi) and are shown in Table 10. Efficiency of all primers was
between 80-110%.
Quantitative PCR was performed by the Utah State University Center for
Integrated Technology (Logan, UT) using Fluidigm Biomark technology and EvaGreen
detection chemistry. The ΔΔCt normalization method was used for relative quantification
as implemented by Fluidigm Real-Time PCR Analysis software, using GAPDH as a
reference gene. Results were analyzed in a mixed model approach implemented in SAS®
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statistical software, Version 9.4, using the “proc mixed” command. Comparisons in
expression of the 13 genes were made between bMEC from the four treatment groups in
each of the 12 cell lines. A significance level was set at p < 0.05.

Results
Cell lines
Primary bMEC lines were established from 12 cattle. The cellular morphology of
all cell lines was consistent with epithelial cells on monolayer culture, and all cell lines
expressed KER8 as determined by PCR. Quality of RNA for all cell lines had an RIN
>7.0.

Effects of PLA2 on proinflammatory gene expression by bMECs
In order to investigate the effects of endogenously administered PLA2 on bMEC
inflammatory responses, we compared the expression of 13 pro-inflammatory genes by
bMECs with and without treatment with PLA2 under unchallenged conditions and
following LPS challenge. These results are shown in Table 11.
None of the 14 genes were significantly differentially expressed between
unchallenged, PLA2-treated bMECs versus unchallenged, untreated bMECs. Four of the
13 genes were significantly differentially expressed between unchallenged and LPSchallenged cell lines with no PLA2 treatment. These were CCL20, IL8, IL1B, and GRO1.
All four were downregulated in LPS-challenged versus unchallenged bMEC. Two of
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these genes, CCL20 and IL1B, were also downregulated in PLA2 treated, LPSchallenged bMEC compared with PLA2 treated, unchallenged bMEC.
Based on these findings, exogenous PLA2 treatment does not affect constitutive
expression of pro-inflammatory genes by bMECs. However, PLA2 has a dampening
effect on the responses of bMECs to LPS, as indicated by a lack of differential IL8 and
GRO1 expression responses by PLA2-treated bMECs in contrast to untreated bMECs.

Discussion
The actions of sPLA2 in inflammation are complex, comprising both stimulatory
and inhibitory effects on other inflammatory factors, and vary by species as well as
tissue. We demonstrate an effect of exogenous PLA2 on pro-inflammatory gene
expression by primary bMECs following LPS challenge but not on constitutive
expression of these genes. Unexpectedly, several pro-inflammatory cytokines were
downregulated in primary bMECs as a result of LPS challenge. Both IL1B and CCL20
were downregulated regardless of PLA2 treatment. Two additional genes, IL8 and
GRO1, were downregulated only in bMECs that were not treated with PLA2.
The chemokine ligand CCL20, also known as macrophage inflammatory protein
3-alpha, is involved in leukocyte migration and formation of ectopic lymphoid tissue
during inflammation [238] as well as possessing antimicrobial activity [239]. The
presence of CCL20 has been demonstrated in human milk early in lactation [240],
indicating a potential role in mammary gland defenses. In cattle, upregulation of CCL20
by the liver occurs in conjunction with leukocytosis following intramammary LPS
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challenge [241]. Although little information is available on the expression of CCL20 in
the bovine mammary gland, our study demonstrates basal expression of CCL20 by
primary bMECs as well as its downregulation by LPS challenge, regardless of the
presence of exogenous PLA2.
Interleukin 1B is a pro-inflammatory cytokine present in the bovine mammary
gland during the acute stages of mastitis caused by a number of mastitis pathogens
[195,221,222] and is involved in neutrophil chemotaxis and adhesion [220]. Our findings
indicate that the expression of IL1B by bMECs is not affected by exogenous PLA2.
Downregulation of IL8 did not occur following LPS challenge in PLA2-treated
bMECs, in contrast to untreated bMECs. Interleukin-8 is a pro-inflammatory chemokine
involved in neutrophil chemotaxis and activation [181]. During acute bovine mastitis,
neutrophils are the major effector leukocyte [242]. Interleukin-8 is upregulated in the
mammary gland during mastitis [195,243] and in bMECs in vitro in response to mastitis
pathogens [157,244]. Correlations between PLA2 and IL8 levels may exist in some
tissues during inflammatory diseases. For example, suppression of PLA2-II during
pancreatitis in rats resulted in decreased serum levels of IL8 and other pro-inflammatory
cytokines [245]. Studies investigating a potential similar correlation are lacking in bovine
mammary tissue. Our results show that exposure to increased levels of PLA2 via
exogenous administration may affect IL8 expression by bMECs following LPS
challenge. However, PLA2 treatment alone, in the absence of LPS, was not sufficient to
alter IL8 expression in these cells.
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Similarly, downregulation of GRO1 in responses to LPS challenge was prevented
by treatment with PLA2. Chemokine (C-X-C motif) ligand 1 is a neutrophil-specific
chemoattractant [246]. Upregulation of GRO1 has been demonstrated in the bovine
mammary gland during mastitis [247] and in a murine model of bovine mastitis following
LPS challenge [248]. Similar to IL8, GRO1 appears to be an important factor in in
neutrophil chemotaxis during bovine mastitis and its expression by primary bMECs
following LPS challenge is influenced by treatment with exogenous PLA2.
Our findings show that exogenous PLA2 affects the expression of two neutrophil
chemotactic factors, IL8 and GRO1, by primary bMECs. Further studies are needed in
order to demonstrate whether exogenous PLA2 has an overall pro- or anti-inflammatory
effect on bMECs and other bovine mammary gland cell types and the bovine mammary
gland in vivo.

Conclusions
This study provides preliminary evidence that exogenously-administered PLA2
may affect the inflammatory responses of the bovine mammary gland. We demonstrated
downregulation of four pro-inflammatory genes following LPS challenge in primary
bMECs. In contrast, bMECs that were concurrently treated with PLA2 demonstrated
downregulation of only two of these genes, CCL20 and IL1B. Future studies are needed
to investigate the effects of exogenous PLA2 on the expression of additional
inflammatory genes by bMEC, other bovine mammary gland cell types, and in vivo
effects.
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Table 10: Primers used for qPCR.
Symbol

Gene

Primer

Sequence

NCBI sequence

CCL20

C-C motif chemokine
ligand 20

F

TTGATGTCAGTGCTATTGCT

NM_174263.2

R

ACCCACTTCTTCTTTGGATC

F

GTGCCCCTTATTTTCCACTA

R

GAGCCCAGAAGAGAAAGTA
G

F

TGTGTTTAACCACCACACC

R

TTGTTCTTTCCACTGTCCA

CCR2

CXCL5

C-C motif chemokine
receptor 2

C-X-C motif chemokine
ligand 5

NM_001194959.1

NM_174300.2

CXCL8

Interleukin 8

F
R

AAACACATTCCACACCTTTC
TCTTCACAAATACCTGCACA

NM_173925.2

GRO1

chemokine (C-X-C motif)
ligand 1

F

ATTCACCTCAAGAACATCCA

NM_175700.1

R

GCACTAGCCTTGTTTAGCAT

IL1A

Interleukin 1 alpha

F
R

GAAGAGGATTCTCAGCTTCC
GATGGGCAACTGATTTGAAG

NM_174092.1

IL1B

Interleukin 1 beta

F
R

CTTGGGTATCAAGGACAAGA
TGAGAAGTGCTGATGTACCA

NM_174093.1

Interleukin 1 receptor
type 1

F

GAGACAATGGAAGTGGTCTT

NM_001206735.1

R

GAAATATTAAGCCGTGCGAG

F

CACTGACTTGAACCAGAACA

R

GCTGGAAGTAGAACTTGGTG

F

AATTCCAGCTAGAACTGAGC

R

TTCCGCAAAGTGGGTTATAA

IL1R1

IL1RN

IL2RG

Interleukin 1 receptor
antagonist

Interleukin 2 receptor
subunit gamma

AB005148.1

NM_174359.1

IL33

Interleukin 33

F
R

CAACCAAGAGAAAGACAAGG
CTCCACAGAGTGCTCCTTAC

NM_001075297.1

IL6

Interleukin 6

F
R

ACTGCTGGTCTTCTGGAGTA
CTTTACCCACTCGTTTGAAG

NM_173923.2

Toll-like receptor 4

F
R

GCATGGAGCTGAATCTCTAC
ATAGGGTTTCCCGTCAGTAT

NM_174198.6

TLR4
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Table 11: Genes downregulated following LPS challenge in untreated and PLA2-treated
bMECs. P-values are shown.
Symbol

Gene

Untreated bMECs
IL1B
Interleukin-1 beta
IL8
Interleukin-8
CCL20
C-C motif chemokine ligand 20
chemokine (C-X-C motif) ligand
GRO1
1
PLA2-treated bMECs
IL1B
Interleukin-1 beta
CCL20
C-C motif chemokine ligand 20

P-value

SE

<0.0001
0.0272
<0.0001

0.7311
1.0043
1.0126

0.0084

0.8879

<0.0001
<0.0001

0.7311
1.0126
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CHAPTER 6
ESTABLISHMENT OF A MILK-DERIVED BOVINE MAMMARY EPITHELIAL
CELL LINE WITH EXTENDED GROWTH CAPABILITIES BY TRANSFECTION
WITH A SIMIAN VIRUS 40 LARGE T ANTIGEN-CONTAINING
PLASMID CONSTRUCT

Abstract
Primary bovine mammary epithelial cells (bMECs) have been used as models of
bovine mammary gland immunity and milk production. However, challenges associated
with the establishment and maintenance of primary bMECs from bovine milk may limit
their use in some studies that require long-term cell line maintenance or large numbers of
cells. Immortalization can facilitate long-term growth of primary bMECs and thereby
improve their versatility. In order to create an immortalized bMEC line, we established
milk-derived primary bMECs and transfected them with a plasmid containing Simian
Virus large T antigen (SV40 L Tag), a protein known to facilitate cell cycle progression
and reduce apoptosis and a well-established method of primary cell immortalization. The
transfected cell line was grown through passage 27 (P27), at which time it was
cryopreserved, with morphologic characteristics of cellular senescence not evident in any
cells after P9. In contrast, all cells in a non-transfected bMEC line established from the
same initial isolation exhibited morphologic characteristics of cellular senescence and
complete cessation of division by P11. Cellular morphologic characteristics and
cytokeratin expression suggest preservation of basic bMEC characteristics. This bMEC
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line could provide a valuable model of the bovine mammary gland with the advantage
over primary bMECs of continued growth. Our establishment of an immortalized bMEC
line derived from bovine milk is unique, and the methods described here could be used in
studies that require the use of continuous cell lines from multiple cows.

Background
Bovine mammary epithelial cells (bMECs) are the milk-producing cells of the
mammary gland, and are also important contributors to innate immunity. Primary bMECs
provide an alternative to animal-based studies within a controlled environment, and have
been used as a model for milk synthesis and secretion [249],the response of the mammary
gland to mastitis-causing pathogens [250], and factors influencing mastitis susceptibility
[204].
Primary bMECs may be established from explant culture or bovine milk.
Establishment of bMECs from bovine milk provides several advantages over explant
culture, including a decreased risk of contamination by other cell types, facilitation of
bMEC line establishment from large numbers of animals, and decreased cost [177]. An
additional advantage of this method that it is non-invasive, minimizing animal pain and
distress as compared with biopsy explant methods and eliminating the need for
euthanasia as required by explant methods using postmortem tissue. These principles are
in keeping with the American Veterinary Medical Association’s policy on the use of
animals in research [199].
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However, a major limitation of milk-derived bMEC establishment is the low
number of cells that can be obtained as compared with explant methods, limiting the use
of this technique in studies that require large numbers of cells [177]. In our experience,
many milk-derived bMEC lines rapidly undergo cellular senescence and a cessation of
division at a low passage number (unpublished data), allowing for only a low number of
population doublings before growth has ceased. Immortalization of primary cell lines
provides a tool by which the division potential of cell lines can be extended. As this
immortalization using SV40 L Tag has been proven in explant-derived bMECs
[196,251], we chose to use this method for immortalization of milk-derived bMECs.
In nature, the SV40 L Tag protein, produced by a simian polyomavirus, promotes
survival and replication of the virus via increasing proliferative potential and decreasing
apoptosis of infected host cells. Host cell expression of SV40 L Tag can result in
tumorigenesis in vivo, and cell line immortalization in vivo [252] through alteration of the
function of tumor suppressor and cell cycle regulatory proteins and suppression of
apoptosis [253].
SV40 large T antigen affects the function of retinoblastoma proteins pRB, p107,
and p130. In the normal cell, pRB proteins serve as a block to progression from the G1 to
S phase of the cell cycle by binding in their hypophosphorylated state to members of the
E2F transcription factor family, preventing E2F-mediated transcription. This block is
lifted in the presence of cyclins E/cdk2 and D1/cdk4, which induce hyperphosphorylation
of pRB proteins and concurrent release of E2F. The SV40 large T antigen induces release
of the normal block on E2F-mediated transcription by binding pRB proteins in their
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hypophosphorylated state, thereby sequestering the proteins so they are unavailable for
binding to E2F. Additionally, SV40 large T antigen promotes dissociation of p130 from
E2F-4 as well as degradation of p130 [6,252].
The SV40 large T antigen additionally affects p53, a tumor suppressor protein. In
the normal cell, p53 levels increase in response to stimuli indicative of cellular damage,
such as when DNA damage occurs. As a transcription factor, p53 promotes transcription
of a number of genes involved in cell cycle arrest and apoptosis, thus preventing
damaged cells from replicating. Important genes involved include p21, bax, cyclin G1,
and mdm2. The SV40 large T antigen, however, is hypothesized to interfere with p53dependent transcription via binding to p53, which results in an inability of p53 to bind
DNA as well as preventing its degradation via the ubiquitin pathway [253].
Another effect of the SV40 large T antigen is through its effects on p300 and
CREB-binding protein (CBP). In the normal cell, these proteins interact with p53, mdm2,
and the NFƙB p65 subunit, contributing to a number of effects including p53-dependent
transcription and degradation of p53. Additionally, CPB/p300 is known to interact with
the E2F-1 transcription factor, increasing its transcriptional activity of factors promoting
cell cycle progression. The SV40 large T antigen binds CPB and p300, possibly in
association with p53, which may facilitate E2F-mediated transcription as well as
inhibition of p53 degradation. SV40 large T antigen has also been shown to bind p400, a
protein similar in structure to p300 and CPB, although the exact function of this protein
and the effects of its interaction with SV40 large T antigen has yet to be defined
[252,253].
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Finally, SV40 large T antigen has anti-apoptotic effects due to a partial structural
homology with the bcl-2 family’s BH1 domain. The BH1 domain is integral to the antiapoptotic activity of the bcl-2 proteins mainly through interaction with pro-apoptotic
proteins Bax and Bak [254]. Additional mechanisms of SV40 large T antigen-induced
transformation and immortalization remain to be fully defined.
Here, we describe the method by which we created an immortalized bMEC line
by transfecting an SV40 L Tag-containing plasmid into first-passage bMECs isolated
from the milk of a Holstein dairy cow. This cell line was grown through passage 27 (P27)
before cryopreservation, with no morphologic evidence of cellular senescence. Although
morphologic features of this cell line were consistent with bMECs and cytokeratin
expression was demonstrated, further investigation is needed to characterize this cell line
for retention of specific bMEC characteristics. This bMEC line could potentially provide
a useful model for bovine mammary gland studies.

Methods and Results
Bovine MEC collection, isolation, and establishment
Bovine MECs were isolated from bovine milk using methods modified from those
previously reported [39,177]. Briefly, 400 ml of bovine milk was collected into an equal
volume of Hank’s Balanced Salt Solution (Sigma-Aldrich, St. Louis, MO) supplemented
with penicillin (60 μg/ml), streptomycin (200 μg/ml), gentamycin (120 μg/ml), and
nystatin (50 mg/L). Milk was subjected to a series of wash and centrifugation steps
similar to those described using a centrifugation speed of 3000 rpm. Bovine MECs
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isolated by this method were seeded into a T-25 culture flask in growth media consisting
of HuMEC Ready Medium (Life Technologies, Grand Island, NY) supplemented with
penicillin (60 μg/ml), streptomycin (200 μg/ml), gentamycin (120 μg/ml), and nystatin
(50 μg/ml), with 10% fetal bovine serum (FBS). Cells were cultured at 38.5°C with 5%
CO2. Growth media was changed after 12 hours and every 2-3 days thereafter.
Cells were passaged after large, coalescing colonies had formed using trypsin
0.05%/EDTA 0.02% (Sigma-Aldrich, St. Louis, MO). Growth media was removed and
cells rinsed with one ml of wash media. One ml of trypsin solution was added and the
culture flask returned to the incubator. Every five minutes, cell lines were observed by
phase-contrast light microscopy for cell detachment. After the majority of cells had
detached, the trypsin solution with suspended cells was removed, added to an equal
volume of growth media, and centrifuged at 2000 rpm for three minutes. The supernatant
was discarded and the cell pellet re-suspended in one ml of growth media, split, and
seeded into 2 T-25 flasks. After reaching confluency, bMECs were trypsinized as
described, with one flask used for transfection (transfected line) as described below and
the other seeded directly into a new T-25 flask (non-transfected line). Cultures were
passaged once 70-100% confluency was reached in all subsequent passages. For all
passages in non-transfected bMECs and up to P16 in transfected bMECs, trypsinized cells
were seeded at a 1:2 or 1:3 dilution. At P16, transfected bMECs were seeded at a 1:6
dilution, and thereafter at a 1:10 dilution until final cryopreservation at P27.
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Transfection of bMECs with SV40 L Tag
Bovine MECs were immortalized by transfection with a plasmid construct
containing the SV40 L Tag amino acids 109-708 (SV40 1:pBSSVD2005, Addgene
plasmid # 21826, David Ron) and an ampicillin resistance gene, provided within
transformed bacteria in an agar stab preparation. Bacteria were plated onto lysogeny
broth (LB) agar containing ampicillin. After incubation at 37°C for 12 hours, a single
bacterial colony was transferred to vial containing 50 ml of LB and incubated at 37°C for
a further 12 hours. Bacteria were pelleted by centrifugation at 4.4 rpm for 6 minutes and
the supernatant discarded. Plasmids were isolated from bacteria using the QIAGEN
Plasmid Plus Midi Prep kit (QIAGEN, Hilden, Germany).
First-passage bMECs were transfected with the SV40 1:pBSSVD2005 plasmid
using the Amaxa 4D-Nucleofector kit (Lonza) and 4D-Nucleofector X Unit (Lonza)
according to the Amaxa 4D-Nucleofector protocol for transfection of human mammary
epithelial cells in suspension. Following trypsinization, approximately 5,000,000 cells
were used for transfection with 5 µg of plasmid. Following transfection, cells were resuspended in growth media and returned to culture conditions.

Cryopreservation of P27 transfected bMECs
Following detachment of bMECs and centrifugation during trypsinization as
described, cell pellets were re-suspended in one ml of growth media with 10% dimethyl
sulfoxide and transferred to two 2-ml capacity cryopreservation tubes. The
cryopreservation tubes were cooled at a rate of approximately -1°C per minute until
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reaching -80°C. After 24 hours, cryopreservation tubes were transferred to a liquid
nitrogen storage unit for long-term storage.

Cell characterization and growth
Verification of epithelial origin of the cultured cells was achieved through
observations of cellular and colony morphology and cytokeratin expression.
Cytokeratin expression was verified by immunocytochemistry in the transfected
(P21) and non-transfected (P2) cell lines using a monoclonal mouse anti-human
cytokeratin antibody (cytokeratin AE1/AE3, product M3515, Dako, Glostrup, Denmark)
and an anti-mouse secondary antibody (Mouse-On-Farma AP-Polymer, product
BRR4010, Biocare Medical, Concord, CA), with IP Warp Red chromogen (product
IPK5024, Biocare Medical) and IP FLX hematoxylin counterstain (IPCS5006, Biocare
Medical). Immunocytochemistry was carried out by the Utah Veterinary Diagnostic
Laboratory (Logan, UT). Both cell lines exhibited cytokeratin expression in the majority
of cells (Figure 2).
Observations of cell colony morphology were made at P0 and subsequent
passages using phase-contrast microscopy. At all passages, both cell lines demonstrated
colony and individual cell morphology consistent with MECs on monolayer [207]. Two
types of cells were recognized, consistent with morphology of milk-derived bMECs
described previously [177]. The first type was characterized by small to moderate
amounts of cytoplasm and formation of colonies. Individualized, squamous-like cells
with large amounts of variably vacuolated cytoplasm comprised the second type.
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Characteristics of the second cell type were considered indicative of cellular senescence,
as these cells exhibited no further division. Small numbers of senescent cells were
observed at P0 to P9 in transfected bMECs but not thereafter. Small to moderate numbers
of senescent cells were observed in non-transfected bMECs at P0 to P7. In subsequent
passages, senescent cells predominated, and comprised all cells at P11. After 30 days at
P11 with no growth observed, this cell line was terminated. The continued growth of
transfected cells with a lack of senescent cells after P9 suggests that immortalization was
successful in removing blocks to cell cycle progression, in contrast with non-transfected
cells that all underwent senescence by P11 (Figure 3). Our laboratory has established
numerous additional non-transfected bMEC lines by the methods described here, all of
which underwent senescence at P10 or earlier (unpublished data).
No steps were undertaken to verify SV40 L Tag expression in the transfected cell
line to verify this mechanism as responsible for the continued growth observed. Nontransfected bMECs were not subjected to sham transfection; therefore, we cannot rule out
the possibility that continued growth was the result of the transfection process itself
rather than SV40 L Tag expression. Nevertheless, promotion of cell cycle progression
through expression of SV40 L Tag is considered most likely.

Conclusions
We established a milk-derived bMEC line with extended growth by transfection
with an SV40 L Tag-containing plasmid. This cell line was successfully grown to
confluence at P27, with cellular morphology consistent with bMECs throughout all
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passages and cytokeratin expression demonstrated at P21. In contrast, a non-transfected
bMEC line established from the same cell line split after P1 ceased further growth and
exhibited cellular morphology consistent with cellular senescence at P11. Further
characterization is needed on this cell line to determine whether characteristics of bMECs
besides cytokeratin expression are preserved, to verify the expression of SV40 L Tag, and
to determine whether growth is continuous after P27. With further characterization, this
cell line could provide a valuable tool as a model for the bovine mammary gland.
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Figure 2: Cytokeratin expression among non-immortalized (A) and immortalized (B)
bMECs. In both bMEC lines, the majority of cells are cytokeratin-positive. Monoclonal
mouse anti-human cytokeratin AE1/AE3 primary antibody; 100x magnification.

Figure 3: Growth rates of transfected and non-transfected bMEC lines from P2 to P22.
Transfection with the SV40 L Tag-containing plasmid in the immortalized line occurred
at P1. The non-immortalized cell line ceased growth at P11.
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CHAPTER 7
CONCLUSIONS

Bovine mastitis results in substantial economic losses to the dairy industry
worldwide and presents considerable animal welfare issues. As such, the development of
strategies to decrease the prevalence of mastitis among dairy cattle is a major focus in the
field of dairy science. Additionally, novel therapeutic approaches are needed in order to
overcome problems associated with reliance on antibiotics as a treatment for mastitis. A
genetic basis for mastitis resistance has previously been demonstrated. Despite relatively
low heritability of some individual mastitis traits, genomic-based approaches to
decreasing mastitis incidence among dairy cattle have proven effective and valuable. The
application of genetics to guide mastitis prevention strategies relies on the identification
of robust genetic markers of mastitis resistance as well as an understanding of the
mechanisms underlying the relevant genetic factors.
My dissertation research identified single nucleotide polymorphism (SNP) genetic
factors and quantitative trait loci of mastitis resistance in Holstein dairy cattle. In
addition, I have demonstrated that bovine mammary epithelial cells (bMECs), the milkproducing cells of the mammary gland, may contribute to mastitis resistance, display
distinct responses from primary bovine fibroblasts (bFs), and respond to exogenouslyadministered phospholipase A2 (PLA2) through differential expression of proinflammatory genes. Additionally, I described a method for establishment of milk-
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derived primary bMECs with extended division potential through transfection with a viral
protein.
Through a genome-wide association study (GWAS) using a selective genotyping
approach and a single-locus mixed model (SLMM), I identified 117 SNPs suggestive of
genome-wide significance for mastitis resistance. From these 117 SNPs, I identified 27
quantitative trait loci (QTLs) potentially associated with mastitis resistance, including ten
QTLs that have not been reported previously. The remaining QTLs overlap with
previously identified QTLs of mastitis or udder conformation traits, including several
QTLS for teat length, suggesting that this trait is potentially important in mastitis
resistance. Additionally, I identified a candidate gene, RAS guanyl releasing Protein 1,
which may be involved in bovine mastitis and is overlapped by a SNP suggestive of
genome-wide association in this study. The cows used in this study were rigorously
phenotypically characterized using multiple measures of intramammary infection status
over an eight-month period. Identification of the most mastitis-resistant and mastitissusceptible animals within the sample population for use in a selective genotyping
approach GWAS may have facilitated identification of the ten novel QTLs.
A subset of the cattle genotyped in the GWAS were selected for establishment of
milk-derived primary bMECs. I used a polymerase chain reaction (PCR) array covering
84 bovine genes relevant to inflammation to examine inflammatory responses of bMEC
from mastitis-resistant and mastitis-susceptible cattle. The constitutive expression of
these 84 genes did not differ between bMECs from mastitis-resistant and mastitissusceptible cattle. However, following a six-hour lipopolysaccharide (LPS) challenge,
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mastitis-resistant bMECs demonstrated differential regulation of 43 genes, while mastitissusceptible bMECs demonstrated differential regulation of one gene only. This gene,
chemokine (C-X-C motif) ligand 5, was upregulated in both groups and is involved in
neutrophil chemotaxis and activation. The differences observed between mastitisresistant and mastitis-susceptible bMECs in this study suggest that rapid differential
expression of inflammatory genes by bMECs in response to inflammatory stimuli may
comprise one mechanism of mastitis resistance in cattle.
To compare the expression of bMEC and bFs, two cell types present in the
mammary gland, I examined the expression of 13 pro-inflammatory genes by primary
bMECs and bFs isolated from the same cattle. These two cell types display differences in
the constitutive expression of six of these genes. As a result of LPS challenge, both cell
types upregulated interleukin-1β, while only bMECs upregulated C-C motif chemokine
ligand 20. Thus, both similarities and differences exist in the responses of these two cell
types to inflammatory stimuli. Because challenges exist in the establishment and
maintenance of primary bMECs, the use of primary bFs could be considered for some but
not all types of bovine mastitis studies.
Phospholipase A2 is an enzyme involved in generation of inflammatory mediators
in mammalian tissues. I demonstrated that PLA2 influences the expression of proinflammatory genes by primary bMECs, reducing their responsiveness to LPS. Whereas
four pro-inflammatory genes out of 13 examined were differentially regulated following
LPS challenge in untreated cells, only two of these genes were differentially regulated
following LPS challenge in bMECs treated concurrently with exogenous bovine PLA2.
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This finding highlights PLA2 as a candidate for future studies to investigate its potential
effects on mastitis severity in cattle.
Cessation of primary bMEC division at early passage numbers presents a major
limitation to their use in some studies requiring large numbers of cells or long-term
maintenance. I describe the establishment of a milk-derived bMEC line with extended
division potential through transfection with simian virus large T antigen (SV40 L Tag), a
protein known to influence progression of the cell cycle and apoptosis. This bMEC line
demonstrated continued division that far exceeded that of a non-transfected line derived
from the same animal, with continued division and an absence of morphologic evidence
of cellular senescence through passage 27 as compared with complete cellular senescence
by passage 11 in the non-transfected line. The methods used to establish this bMEC line,
as well as the cell line itself, could facilitate future studies using the bMEC model.
Collectively, the findings of this dissertation research contribute to knowledge of
genetic factors of mastitis resistance in dairy cattle, the underlying molecular mechanisms
that may be involved, and the use and versatility of a primary bMEC-based model for
bovine mammary gland studies.
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APPENDIX A
Table 12: Single nucleotide polymorphisms suggestive of genome-wide significance for
bovine mastitis resistance. The allele associated with mastitis resistance is shown.
Marker

Chr

Position

-log10(P-Value)

Protective Allele

rs43358044
rs137266495
rs109319807
rs136808611
rs136937812
rs110284739
rs109526058
rs134217424
rs111020787
rs109587178
rs135295512
rs110055960
rs109308232
rs43506128
rs134337435
rs135850795
rs41879780
rs42748473
rs135442750
rs110555626
rs109816246
rs42781654
rs43616389
rs110785064
rs133822572
rs109701184
rs134262073
rs110866096
rs41604830
rs43354976
rs135734418
rs43700325
rs43701535
rs109119871
rs43701552
rs43048540
rs42306995
rs135443516
rs133087401
rs134332052
rs135270243

3
3
4
27
X
10
12
15
10
10
9
15
10
7
18
18
18
27
17
17
17
17
10
14
14
2
2
10
26
3
10
11
11
11
11
11
17
9
9
9
9

91840020
91852910
101537884
42783896
57802477
27951935
84803111
51068247
15230978
34260761
53003499
3927915
34184801
32204119
43565043
43566644
43568721
151528
41733436
41739893
41753937
41758421
14261766
40832903
40834978
135044225
135061232
34482573
28196945
92983189
29032168
29205354
29206310
29207614
29208446
29228506
41702459
65859392
65860153
65861243
65879171

3.996653467
3.996653467
3.980910125
3.97700887
3.975335219
3.974500075
3.964518728
3.952684594
3.939244754
3.936591969
3.929227883
3.9101623
3.903017995
3.894230637
3.869328826
3.869328826
3.869328826
3.866788625
3.843632627
3.843632627
3.843632627
3.843632627
3.839667402
3.835638804
3.835638804
3.826885025
3.826885025
3.826134783
3.815561566
3.802056534
3.77771954
3.763347317
3.763347317
3.763347317
3.763347317
3.763347317
3.761873315
3.753918619
3.753918619
3.753918619
3.753918619

G
A
T
A
A
A
C
G
T
C
C
C
G
C
T
C
G
C
A
G
T
T
T
C
G
A
G
T
G
A
T
G
A
G
G
A
G
A
C
C
G

rs133800930
rs137234024

9
9

65889358
65890250

3.753918619
3.753918619

T
C

182
rs136293798
rs136979275
rs109202959
rs134340673
rs109711228
rs135987526
rs136467850
rs43618989
rs111023847
rs110918390
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rs109403663
rs108942580
rs109726329
rs110132689
rs109513395
rs110663077
rs42435974
rs137733108
rs42422111
rs42422098
rs42422096
rs110502897
rs109139712
rs135391817
rs43488809
rs109048873
rs109752781
rs135575219
rs41611251
rs109407328
rs110264878
rs109199653
rs137323892
rs136457662
rs41856186
rs109442613
rs110805371
rs134256203
rs42230220
rs110803408
rs41708297
rs109484288
rs109133788
rs136768665
rs109699387
rs43617435
rs43616344

9
9
19
10
15
28
15
10
16
16
16
16
16
16
16
16
10
26
12
3
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3
6
10
10
6
17
17
17
17
17
17
17
19
29
18
18
10
29
10
9
13
6
18
3
11
10
10

65891235
65895727
7514783
15144718
50978021
18520683
54649868
11496248
20608750
20609335
20610171
20612167
20614885
20615451
20616455
20617139
39854351
28877559
12976126
90823349
90825605
90826586
45848609
11478732
11482238
109419395
37988898
37999567
41741046
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41742777
41746116
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11786116
28578533
5214466
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34407598
46072112
29751247
103674333
61537602
108468990
49684020
91342794
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14229935
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3.753918619
3.753918619
3.746281982
3.7416025
3.719140182
3.714851977
3.704686149
3.701449371
3.694447987
3.694447987
3.694447987
3.694447987
3.694447987
3.694447987
3.694447987
3.694447987
3.693917704
3.677934056
3.675972311
3.675190282
3.675190282
3.675190282
3.668025217
3.666290057
3.666290057
3.661360545
3.653290211
3.653290211
3.651960319
3.651960319
3.651960319
3.651960319
3.651960319
3.64943487
3.648974591
3.648636063
3.648636063
3.64764349
3.640522943
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47304572
47305423
47306109
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47358546
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SUMMARY
American College of Veterinary Pathologists Board-certified veterinary anatomic
pathologist. Currently working as a Clinical Assistant Professor (Temporary) and
Extension Veterinary Pathologist for the Utah Veterinary Diagnostic Laboratory, Utah
State University. PhD in animal molecular genetics at Utah State University. Veterinary
graduate of the University of Edinburgh, Scotland. Supporting BS degree in in animal
science, and experience in veterinary research, regulated laboratory procedures, and
livestock husbandry. Member of the Royal College of Veterinary Surgeons (United
Kingdom), and licensed veterinarian in the state of Utah.

EDUCATION
Veterinary Anatomic Pathology Residency – 2011 to 2017
Utah Veterinary Diagnostic Laboratory, Utah State University – Logan, UT
PhD, Animal Molecular Genetics – 2012 to 2017
Utah State University – Logan, UT
BVM&S, with Distinction – 2010
University of Edinburgh, Royal (Dick) School of Veterinary Studies – Edinburgh, UK
AVMA-accredited veterinary degree.
BS, Animal Science, magna cum laude – 2006
Cornell University, College of Agriculture and Life Sciences – Ithaca, NY
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EXPERIENCE
UTAH STATE UNIVERSITY

2017-Present

Clinical Assistant Professor, Temporary, Animal, Dairy, and Veterinary Science
American College of Veterinary Pathologists Board-certified anatomic veterinary
pathologist with extension veterinary pathologist (70%), teaching (25%), and
departmental service (5%) duties. Extension veterinary pathologist duties include
performance, interpretation, and reporting of necropsies, histopathology, and ancillary
testing. Teaching responsibilities include assistance of primary instructors for general and
systemic veterinary pathology courses in the USU veterinary school, resident training,
and organization and teaching of resident seminar series. Departmental service duties
encompass service on departmental committees.

UTAH STATE UNIVERSITY

2011-2017

Veterinary Anatomic Pathology Residency
Veterinary residency working toward eligibility for Board certification under the American
College of Veterinary Pathologists. Duties involved primary case responsibility for animals
submitted for necropsy and samples submitted for surgical pathology, and graduate
teaching assistant assignments in Microscopic Anatomy, General Pathology, and Systemic
Pathology at the veterinary school level.

UNIVERSITY OF EDINBURGH AND AVIAGEN – Edinburgh, UK

2010

Poultry Medicine Elective Rotation
Veterinary rotation working with the poultry veterinary service at the University of
Edinburgh and the global poultry genetics company Aviagen. Duties performed included
poultry handling, health and welfare assessment, disease detection and treatment, post
mortem examination, egg quality assessment, and flock management.
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UNIVERSITY OF EDINBURGH, VETERINARY PATHOLOGY UNIT –
Edinburgh, UK

2009

Research Assistant
Member of scientific research team investigating causes of mortality in red squirrels in
Scotland, contributing to knowledge vital to wildlife conservation efforts. Lead author on
resulting publication.
VETERINARY PRACTICES AND SERVICES – UK and USA
2008-2010
Clinical Veterinary Extramural Work
Placements
Clinical veterinary work external to university schooling included placements in small
animal practice (10 weeks), farm animal practice (2 weeks), farm assurance assessment (2
weeks), equine hospital/intensive care (2 weeks), exotics/wildlife hospital (1 week), and
abattoir (1 week). Duties included assistance with client consultations, clinical
examination, patient monitoring and treatment, disease diagnosis, surgery, post mortem
examination, herd health evaluation, and welfare assessment.
ADVION BIOSERVICES – Ithaca, NY

2001-2006

Laboratory Technician Intern
Performed and documented instrument and laboratory maintenance, sample custody, and
clinical supply logistics in a regulated bioanalytical laboratory.

CORNELL UNIVERSITY SHEEP RESEARCH & TEACHING
UNIT – Hartford, NY

2002-2005

Farm Worker
Responsible for the husbandry of sheep, including lambing ewes and lambs, in a 750-ewe
flock.
HEGDALE FARM – Cumbria, UK

2004

Resident Farm Worker
Responsible for the daily husbandry and management of sheep, calves, pigs, and free-range
poultry on a small family-run farm.
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PROFESSIONAL AFFILIATIONS
Diplomate, American College of Veterinary Pathologists
Licensed veterinarian, state of Utah
Member of the Royal College of Veterinary Surgeons (United Kingdom)
PUBLICATIONS
A.J. Van Wettere, J. P. Kurz, A. Wilhelm, and J. D. Ipsen. Opisthotonos and unilateral
internal hydrocephalus associated with aberrant migration of Serratospiculum spp. in a
prairie falcon (Falco mexicanus). Journal of Veterinary Diagnostic Investigation,
accepted 2017.
D. J. Wilson and J. P. Kurz. (2017) Genetic sequencing using 16S rRNA for pathogen
identification in retropharyngeal lymph nodes from wild elk. Human-Wildlife Interactions
11(1), 19-21.
J. P. LaRose, A.L. Meredith, D.J. Everest, C. Fiegna, C.J. McInnes, D.J. Shaw, and E.M.
Milne. (2010) Epidemiological and post-mortem findings from 262 red squirrels (Sciurus
vulgaris) in Scotland (2002-2009). Veterinary Record 167, 297-302.
AWARDS
2014 College of Agriculture and Applied Sciences Graduate Student Teacher of the Year.
Utah State University, Logan, Utah. 18 September 2014.
2013 Utah State University Animal, Dairy, and Veterinary Science Department Graduate
Student Symposium, 1st place PhD track oral presentation. Utah State University, Logan,
UT. 5 August 2013.

LECTURES
“Genetic Markers of Bovine Mastitis Resistance.” Animal, Dairy, and Veterinary
Science/Center for Integrated Biotechnology Seminar Series. Utah State University,
Logan, UT. 7 September 2017.
“Lecture Series: Lower GI System: Intestine, Parts I, II, and III.” Systemic Pathology,
VM 7546. Utah State University, Logan, UT. September 2017, September 2016, and
September 2015.
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“Lecture series: Ruminant Stomach, Parts I and II.” Systemic Pathology, VM 7546. Utah
State University, Logan, UT. September 2017, September 2016, September 2015, and
September 2014.
“Case Study: Hyperkalemic Periodic Paralysis in a Quarter Horse.” Veterinary Physiology
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